Search Result

Results for "

CD

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ALCAM/CD166 (1) c-Kit (4) CD19 (14) CD2 (2) CD20 (18) CD22 (7) CD276/B7-H3 (2) CD28 (11) CD3 (32) CD38 (17) CD6 (1) CD73 (32) CD74 (1) CTLA-4 (1) FLT3 (1) LAG-3 (1) 5-HT Receptor (5) Acetolactate Synthase (ALS) (1) ADC Antibody (14) ADC Cytotoxin (11) ADC Linker (1) Adenosine Receptor (1) Adrenergic Receptor (5) Aldehyde Dehydrogenase (ALDH) (1) Aminopeptidase (7) Amyloid-β (1) Androgen Receptor (2) Angiotensin Receptor (1) Antibiotic (25) Antibody-Drug Conjugates (ADCs) (6) Apelin Receptor (APJ) (6) Apoptosis (44) Arenavirus (1) Aryl Hydrocarbon Receptor (5) Aurora Kinase (5) Autophagy (38) Bacterial (31) Bcr-Abl (1) BCRP (1) Biochemical Assay Reagents (9) Btk (3) c-Fms (1) c-Met/HGFR (1) Calcineurin (2) Calcium Channel (3) Caspase (2) CDK (1) Complement System (16) COX (9) CRAC Channel (1) CRISPR/Cas9 (1) CXCR (5) Cytochrome P450 (5) Dipeptidyl Peptidase (3) DNA/RNA Synthesis (7) Dopamine Receptor (3) Drug Metabolite (6) Drug-Linker Conjugates for ADC (5) E1/E2/E3 Enzyme (1) EGFR (3) Endogenous Metabolite (44) Epigenetic Reader Domain (4) ERK (1) Estrogen Receptor/ERR (1) FAAH (1) Factor Xa (1) Ferroptosis (3) FGFR (4) FKBP (1) Fluorescent Dye (3) Fungal (5) GABA Receptor (1) Galectin (1) Glucocorticoid Receptor (11) Glutaminase (1) GnRH Receptor (1) HBV (1) HCV (4) HCV Protease (1) HDAC (3) Histamine Receptor (9) Histone Demethylase (2) Histone Methyltransferase (1) HIV (24) HIV Protease (1) HMG-CoA Reductase (HMGCR) (1) IFNAR (4) IGF-1R (1) Indoleamine 2,3-Dioxygenase (IDO) (3) Influenza Virus (4) Integrin (9) Interleukin Related (21) IRAK (2) Isotope-Labeled Compounds (149) Itk (1) JAK (2) Kinesin (1) Lactate Dehydrogenase (1) Legumain (1) Leukotriene Receptor (3) Ligands for E3 Ligase (1) Liposome (3) LPL Receptor (1) mAChR (1) MAP4K (1) MAPKAPK2 (MK2) (1) Mas-related G-protein-coupled Receptor (MRGPR) (2) MEK (1) Microtubule/Tubulin (8) Mitophagy (10) Molecular Glues (1) Necroptosis (1) Neurokinin Receptor (1) NF-κB (3) NO Synthase (2) Notch (2) Nucleoside Antimetabolite/Analog (2) Opioid Receptor (2) Orexin Receptor (OX Receptor) (2) P2X Receptor (1) P2Y Receptor (1) p38 MAPK (1) PAI-1 (1) Parasite (9) PD-1/PD-L1 (18) PDGFR (5) Phosphatase (10) Phosphodiesterase (PDE) (2) Phospholipase (1) PI3K (2) Polo-like Kinase (PLK) (1) Potassium Channel (1) Progesterone Receptor (1) PROTACs (1) Proteasome (1) Proton Pump (1) Pyroptosis (1) Raf (3) RAR/RXR (13) Reactive Oxygen Species (2) RET (1) ROR (4) SARS-CoV (14) Serotonin Transporter (1) SHP2 (2) Small Interfering RNA (siRNA) (96) Sodium Channel (2) STAT (2) STING (4) TGF-beta/Smad (2) TGF-β Receptor (3) Thrombin (1) Thymidylate Synthase (1) TNF Receptor (41) Toll-like Receptor (TLR) (6) Topoisomerase (1) Trk Receptor (2) TRP Channel (1) VD/VDR (1) VEGFR (7) Virus Protease (3)
By Research Areas:	Cancer (371) Cardiovascular Disease (27) Endocrinology (21) Infection (79) Inflammation/Immunology (230) Metabolic Disease (51) Neurological Disease (52)
Click Chemistry:	Azide (1) Alkynes (1)

765

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

MCE Kits

321

Inhibitory Antibodies

Natural
Products

2316

Recombinant Proteins

190

Isotope-Labeled Compounds

279

Antibodies

Click Chemistry

CD80-IN-3
CD80-IN-3, a potent *CD80* inhibitor, inhibits CD80/CD28 interaction with an EC₅₀ of 630 nM and a K_d of 125 nM.

CD73-IN-4	CD73	Inflammation/Immunology Cancer
CD73-IN-4 is a potent and selective methylenephosphonic acid *CD73* inhibitor, with an IC₅₀ of 2.6 nM for human CD73. CD73-IN-4 is potential for the research of cancer immunology .

CD235	Epigenetic Reader Domain	Cancer
CD235 is a structurally similar analogue of CD161. CD161 is a potent and orally bioavailable BET bromodomain inhibitor .

CD63-1 aptamer sodium	Others	Cancer
CD63-1 aptamer sodium is a high-affinity and specific DNA aptamer targeting the CD63 protein (Kd: 38.71 nM). CD63-1 aptamer sodium efficiently binds to CD63-positive cells, including breast cancer MDA-MB-231 cells and CD63-overexpressing HEK293T cells, with moderate binding affinity (Kd~100 nM) as assessed by flow cytometry .

CD63-2 aptamer sodium	Others	Cancer
CD63-2 aptamer sodium is a high-affinity and specific DNA aptamer targeting the CD63 protein (Kd: 78.43 nM). CD63-1 aptamer sodium efficiently binds to CD63-positive cells, including breast cancer MDA-MB-231 cells and CD63-overexpressing HEK293T cells, with moderate binding affinity (Kd~100 nM) as assessed by flow cytometry .

CD12681	ROR	Inflammation/Immunology
CD12681 (compound 14) is a potent and selective RORγ inverse agonist with IC₅₀ of 19 nM and 10 nM for RORγ GAL4 and CD4-IL-17 cells, respectively. CD12681 decreases the IL-17 inflammatory cell recruitment. CD12681 has the potential for the research of psoriasis .

CD73-IN-6	CD73	Cancer
CD73-IN-6 is a *CD73* inhibitor extracted from patent WO2022007677A1 compound 2. CD73-IN-6 can be used for the research of cancer .

CD73-IN-13	CD73	Cancer
CD73-IN-13 is a potent inhibitor of *CD73*. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-13 be used for preparing a medicament for tumor-related diseases (extracted from patent CN114437039A, compound 7) .

CD73-IN-12	CD73	Cancer
CD73-IN-12 is a potent inhibitor of *CD73*. CD73 is closely associated with tumor growth, angiogenesis and metastasis. CD73-IN-12 be used for preparing a medicament for tumor-related diseases (extracted from patent CN114437038A, compound 9) . CD73-IN-12 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

CD 10899	Polo-like Kinase (PLK)	Cancer
CD 10899 is a hydroxylated metabolite of Volasertib (HY-12137). CD 10899 is pharmacologically active against Polo-like kinase 1 (PLK1) (IC₅₀: 6 nM). Volasertib is an orally active, highly potent and ATP-competitive PLK1 inhibitor. CD 10899 can be used for research of cancer .

CD532	Aurora Kinase	Cancer
CD532 is a potent Aurora A kinase inhibitor with an IC₅₀ of 45 nM. CD532 has the dual effect of blocking Aurora A kinase activity and driving degradation of MYCN. CD532 also can directly interact with AURKA and induces a global conformational shift. CD532 can be used for the research of cancer .

CD532 hydrochloride	Aurora Kinase	Cancer
CD532 hydrochloride is a potent Aurora A kinase inhibitor with an IC₅₀ of 45 nM. CD532 hydrochloride has the dual effect of blocking Aurora A kinase activity and driving degradation of MYCN. CD532 hydrochloride also can directly interact with AURKA and induces a global conformational shift. CD532 hydrochloride can be used for the research of cancer .

CD73-IN-5	CD73	Cancer
CD73-IN-5 is a potent and selective non-nucleotide small molecule inhibitor of *CD73* (IC₅₀ = 19 nM).

CD00509	Phosphodiesterase (PDE)	Cancer
CD00509 is a Tdp1 inhibitor, with an IC₅₀ value of 0.71 μM. CD00509 can sensitize breast cancer cells to Camptothecin (HY-16560). CD00509 has anti-tumor activity .

CD73-IN-3	CD73	Cancer
CD73-IN-3 is a potent *CD73* inhibitor (IC₅₀=7.3 nM in Calu6 human cell assay). CD73-IN-3, example 2 extracted from patent WO2019168744 A1, has the potential for cancer research .

CD73-IN-7	CD73	Cancer
CD73-IN-7 is a potent inhibitor of *CD73*. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-7 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022052886A1, compound 13) .

CD73-IN-8	CD73	Cancer
CD73-IN-8 is a potent inhibitor of *CD73*. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-8 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022052886A1, compound 57) .

CD73-IN-9	CD73	Inflammation/Immunology
CD73-IN-9 is a potent inhibitor of *CD73*. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-9 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 2) .

CD73-IN-11	CD73	Inflammation/Immunology Cancer
CD73-IN-11 is a potent inhibitor of *CD73*. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-11 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 24) .

CD73-IN-10	CD73	Inflammation/Immunology Cancer
CD73-IN-10 is a potent inhibitor of *CD73*. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP), and adenosine can induce immunosuppressive effects and promote tumor proliferation and/or metastasis. CD73-IN-10 be used for preparing a medicament for tumor-related diseases (extracted from patent WO2022068929A1, compound 4) .

CD73-IN-2	CD73	Cancer
CD73-IN-2 is a potent *CD73* inhibitor extracted from WO2020151707A1, example 1, has an IC₅₀ of 0.09 nM .

CD73-IN-14	CD73	Cancer
D73-IN-14 is a potent, selective and orally active *CD73* inhibitor with an IC₅₀ value of 0.17 nM. CD73-IN-14 increases the number of tumor-infiltrating CD8 ⁺ cells and shows anti-tumor activity . CD73-IN-14 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

CD19 CAR mRNA	CD19	Inflammation/Immunology Cancer
CD19 CAR mRNA will express CD19 car protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.

CD19 CAR circRNA	CD19	Inflammation/Immunology Cancer
CD19 CAR circRNA will express CD19 car protein, and can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction.

CD73-IN-1	CD73	Cancer
CD73-IN-1 is an inhibitor of *CD73* which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.

CD24/Siglec-10 blocking peptide, CSBP	PD-1/PD-L1	Cancer
CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .

CD19 car circRNA-LNP	CD19 Liposome	Inflammation/Immunology Cancer
CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

CD19 car mRNA-LNP	CD19 Liposome	Inflammation/Immunology Cancer
CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

CD33 splicing modulator 1	Others	Neurological Disease
CD33 splicing modulator 1 (Compound 1) is a CD33 splicing modulator. CD33/Siglec 3 is a myeloid lineage cell surface receptor that is known to regulate microglia activity. CD33 splicing modulator 1 increases exon 2 skipping in cellular mRNA pools. CD33 splicing modulator 1 has the potential for the research of neurodegenerative disease including Alzheimer's disease .

CD33 splicing modulator 1 hydrochloride	Others	Neurological Disease
CD33 splicing modulator 1 (Compound 1) hydrochloride is a CD33 splicing modulator. CD33/Siglec 3 is a myeloid lineage cell surface receptor that is known to regulate microglia activity. CD33 splicing modulator 1 hydrochloride increases exon 2 skipping in cellular mRNA pools. CD33 splicing modulator 1 hydrochloride has the potential for the research of neurodegenerative disease including Alzheimer's disease .

CD38 inhibitor 1 5+ Cited Publications	CD38	Metabolic Disease
CD38 inhibitor 1 (compound 78c) is a potent *CD38* inhibitor with IC₅₀s of 7.3 nM and 1.9 nM for hCD38 and mouse CD38 .

CD22 ligand-1	CD22	Cancer
CD22 ligand-1 (compound 12) is a potent and selective *CD22* ligand with K_D of 0.335, 30.7 µM for hCD22 and MAG, respectively. CD22 ligand-1 has the potential for the research of B-cell related disease .

CD38 inhibitor 2	CD38	Cancer
CD38 inhibitor 2 is a potent *CD38* inhibitor (IC₅₀ = 0.01 ~ 0.1 μΜ).

CD31 PECAM-1	SHP2 Bacterial	Metabolic Disease Inflammation/Immunology
CD31 (PECAM-1) is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). CD31 is also an ER-MP12 antigen, acts as a linker between mechanical stress, metabolism and inflammation. CD31 peptide is able to sustain phosphorylation of the CD31 ITIM₆₈₆ and of SHP2 and to inhibit TCR-induced T-cell activation ^- .

CD3254 3 Publications Verification	RAR/RXR	Metabolic Disease Cancer
CD3254 a potent and selective retinoid-X-receptor (RXR) agonist .

CD38 inhibitor 3	CD38	Metabolic Disease
CD38 inhibitor 3 (compound 1) is a potent CD38 inhibitor (IC₅₀=11 nM). CD38 inhibitor 3 can promote mitochondrial biogenesis, reduce lactate levels, and increase NAD+ content and Nrf2 expression. In a model of mitochondrial myopathy, CD38 inhibitor 3 increases muscle contraction/development and improves exercise tolerance in Pus1 ^-/- mice .

Englumafusp alfa CD19-4-1BBL; RO7227166; RG6076	CD19	Cancer
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct comprised of a *CD19*-specific antibody domain fused to a trimerized extracellular domains of human 41BBL. Englumafusp alfa promotes CD19-specific 4-1BB cross-linking on the surface of T and NK cells .

CD1530	RAR/RXR	Cancer
CD1530 is a selective RARγ agonist with an K_d of 150 nM . CD1530 has been used in combination with bexarotene to inhibit oral carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide in a mouse model of human oral-cavity and esophageal squamous-cell carcinoma .

CD437 2 Publications Verification AHPN	RAR/RXR Autophagy	Cancer
CD437 is a selective Retinoic Acid Receptor γ (RARγ) agonist.

CD2314	RAR/RXR	Cancer
CD2314 is a potent and selective RARβ receptor agonist with a K_d of 195 nM in S91 melanoma cells .

CD31 TFA PECAM-1 TFA	SHP2 Bacterial	Metabolic Disease Inflammation/Immunology
CD31 (PECAM-1) TFA is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). CD31 TFA is also an ER-MP12 antigen, acts as a linker between mechanical stress, metabolism and inflammation. CD31 TFA peptide is able to sustain phosphorylation of the CD31 ITIM₆₈₆ and of SHP2 and to inhibit TCR-induced T-cell activation ^- .

CD437-13C6 AHPN-¹³C₆	Isotope-Labeled Compounds RAR/RXR Autophagy	Cancer
CD437- ¹³C₆ is the ¹³C- and deuterium labeled CD437. CD437 is a selective Retinoic Acid Receptor γ (RARγ) agonist.

Trifarotene CD5789	RAR/RXR Autophagy	Inflammation/Immunology
Trifarotene (CD5789) is a potent and selective RARγ agonist. Trifarotene (CD5789) shows ∼65-fold and ∼16-fold selectivitiy for the RARγ (EC₅₀=7.7 nM) over RARα (EC₅₀=500 nM) and RARβ (EC₅₀=125 nM), respectively .

CD2665	RAR/RXR	Metabolic Disease
CD2665 is an orally active and selective RAR-β,γ antagonist, with K_d values of 306 nM, 110 nM for RAR-β and RAR-γ, repectively .

CD109 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CD109 Human Pre-designed siRNA Set A contains three designed siRNAs for CD109 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CD14 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
CD14 Human Pre-designed siRNA Set A contains three designed siRNAs for CD14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Cat. No.	Product Name

HY-L177

Antibody Inhibitor Library

21 Compounds compounds

Antibody inhibitors are compounds with the same activity as the original therapeutic antibodies, which can be used as positive controls for drug efficacy evaluation and other studies. Antibody inhibitors can also assist in verifying the functional activity of the target protein. These antibody inhibitors are active in vivo and can achieve certain physiological functions by blocking or neutralizing target proteins, such as CD20, HER2, EGFR, VEGFR, TNF-α, etc. In drug screening, antibody inhibitor-based screening can be carried out to identify active compounds targeting target proteins and target diseases.

MCE can provide 21 antibody inhibitors that can be used for drug development in cancer, immunity, infection and other hot research areas.

Cat. No.	Product Name	Type

HY-10475G

AM580 (GMP) CD336 (GMP); NSC608001 (GMP); Ro 40-6055 (GMP)	Fluorescent Dye
AM580 (CD336) (GMP) is AM580 (HY-10475) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. AM580 is a selective RARα agonist .

HY-D1124

Mordant brown 1	Dyes
Mordant brown 1, a naphthalenesulphonic acid derivative, is an azo dye. Mordant brown 1 is also an effective and specific inhibitor of CD40-CD154 costimulatory protein-protein interaction .

HY-15579G

MMAF (GMP) Monomethylauristatin F (GMP)	Fluorescent Dye
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .

HY-15579BG

MMAF sodium (GMP) Monomethylauristatin F sodium (GMP)	Fluorescent Dye
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .

Cat. No.	Product Name	Type

HY-10475G

AM580 (GMP) CD336 (GMP); NSC608001 (GMP); Ro 40-6055 (GMP)	Biochemical Assay Reagents
AM580 (CD336) (GMP) is AM580 (HY-10475) produced by using GMP guidelines. GMP small molecules works appropriately as an auxiliary reagent for cell therapy manufacture. AM580 is a selective RARα agonist .

HY-P2983

Angiotensin-converting enzyme ACE; kininase II; CD143	Biochemical Assay Reagents
Angiotensin-converting enzyme (ACE) is a dicarboxypeptidase, it converts inactive Angiotensin I (Ang I) to active Ang II and degrades active bradykinin (BK). Angiotensin-converting enzyme is a potent vasoconstrictor, is often used in biochemical studies .

HY-17031

SBE-β-CD 75+ Cited Publications Sulfobutylether-β-Cyclodextrin	Co-solvents
SBE-β-CD is a sulfobutylether β-cyclodextrin derivative used as an excipient or a formulating agent to increase the solubility of poorly soluble agents .

HY-153234

CD19 car circRNA-LNP

Drug Delivery

CD19 car circRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car circRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car circRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

HY-153233

CD19 car mRNA-LNP

Drug Delivery

CD19 car mRNA-LNP is a lipid nanoparticle (LNP) containing CD19 car mRNA, suitable for detection of RNA delivery, translation efficiency, cell viability, etc. CD19 car mRNA can be used in chimeric antigen receptor T cell immunotherapy (CAR-CD19). The CD19 car is a chimeric antigen receptor. Among them, CD19 is a CD molecule expressed by B cells (i.e. leukocyte differentiation antigen), an important membrane antigen involved in B cell proliferation, differentiation, activation and antibody production, and can also promote BCR signal transduction .

HY-101103

HP-β-CD 10+ Cited Publications (2-Hydroxypropyl)-β-cyclodextrin	Drug Delivery
HP-β-CD ((2-Hydroxypropyl)-β-cyclodextrin) is a widely used drug delivery vehicle to improve the stability and bioavailability.

HY-18593

Mal-β-CD

6-O-alpha-D-Maltosyl-beta-cyclodextrin
Biochemical Assay Reagents

Mal-β-CD is a cellular cholesterol modifier which can form soluble inclusion complex with cholesterol.

HY-137234

DM-β-CD

2,6-Di-O-methyl-β-cyclodextrin

Biochemical Assay Reagents

DM-β-CD (2,6-Di-O-methyl-β-cyclodextrin) is a cyclic molecule consisting of seven glucose units modified with two methyl groups at the 2- and 6-positions. It is usually used as a solubilizer and carrier for poorly soluble drugs in pharmaceutical preparations. Furthermore, it has applications in analytical chemistry, food science, and environmental remediation due to its ability to form clathrates with various guest molecules, such as aromatic compounds, pesticides, and heavy metals.

HY-P2969

Complement factor I	Biochemical Assay Reagents
Complement factor I is a serine protease that downregulates complement activity in the fluid phase and/or on cell surfaces in conjunction with one of its cofactors, factor H (FH), complement receptor 1 (CR1/CD35), C4 binding protein (C4BP) or membrane cofactor protein (MCP/CD46) .

HY-E70158

Fucosyltransferase 9 EC:2.4.1.152; FUT9	Enzyme Substrates
Fucosyltransferase 9 (EC:2.4.1.152, FUT9) catalyzes the last step in the biosynthesis of Lewis antigen, the addition of a fucose to precursor polysaccharides. Fucosyltransferase 9 synthesizes the LeX oligosaccharide (CD15) .

HY-126726

KOdiA-PC

Biochemical Assay Reagents

Oxidized low-density lipoprotein (oxLDL) particles contain low molecular weight species that are cytotoxic and proatherogenic. Many of these species were recently isolated and purified from oxLDL and identified as phosphatidylcholine species containing fragmented oxidized short-chain fatty acid residues at the sn-2 position. 1-(Palmitoyl)-2-(5-keto-6-octene-dioyl)phosphatidylcholine or KOdiA-PC is one of the most potent CD36 ligands of the oxLDL species. KOdiA-PC confers CD36 scavenger receptor binding affinity to LDL at a frequency of only 2 to 3 KOdiA-PC molecules/LDL particle and may be one of the more important structural determinants of oxLDL.

HY-151506

Phospholipid PL1	Drug Delivery
Phospholipid PL1 is a phospholipid-derived nanoparticle, can deliver costimulatory receptor mRNA (CD137 or OX40) to T cells. Phospholipid PL1 could induce the activation of various immune cells, including T cells and dendritic cells (DCs) in order to boost antitumor immunity .

HY-15579G

MMAF (GMP) Monomethylauristatin F (GMP)	Biochemical Assay Reagents
MMAF (Monomethylauristatin F) GMP is a GMP grade MMAF (HY-15579). MMAF (Monomethylauristatin F) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF (Monomethylauristatin F) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin and SGN-CD19A .

HY-15579BG

MMAF sodium (GMP) Monomethylauristatin F sodium (GMP)	Biochemical Assay Reagents
MMAF sodium GMP is a GMP grade MMAF (sodium) (HY-15579B). MMAF sodium (Monomethylauristatin F sodium) is a potent tubulin polymerization inhibitor and is used as a antitumor agent. MMAF sodium (Monomethylauristatin F sodium) is widely used as a cytotoxic component of antibody-drug conjugates (ADCs) such as Vorsetuzumab mafodotin and SGN-CD19A .

HY-W145643

Mono-6-O-(p-toluenesulfonyl)-γ-cyclodextrin Mono-6-O-(p-toluenesulfonyl)-gamma-cyclodextrin; Ts-γ-CD	Biochemical Assay Reagents
Mono-6-O-(p-toluenesulfonyl)-γ-cyclodextrin is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

Cat. No.	Product Name	Target	Research Area

HY-P10091

CD24/Siglec-10 blocking peptide, CSBP	PD-1/PD-L1	Cancer
CD24/Siglec-10 blocking peptide, CSBP can not only block the interaction of CD24/Siglec-10 but also PD-1/PD-L1. CD24/Siglec-10 blocking peptide, CSBP can induce the phagocytosis of tumor cell .

HY-P10183

CD36 Peptide P (139-155), Cys conjugated Cys-CD36(139-155)	Peptides	Inflammation/Immunology
CD36 Peptide P (139-155), Cys conjugated is a Cys labelled CD36 Peptide, and can inhibit the immunoadsorption of CD36 by OKM5 .

HY-P5813

Cd1a β-TRTX-CD1a; β-Theraphotoxin-CD1a	Peptides	Neurological Disease
Cd1a is a β-toxin derived from the African spider Ceratogyrus darlingi. Cd1a can regulate calcium ion channels. Cd1a inhibits human calcium ion channels (Ca_v2.2)(IC₅₀2.6 μM) and mouse sodium ion channels (Na_v1.7). Cd1a can be used in the development of peripheral pain treatment drugs .

HY-P3444

CD31 PECAM-1	SHP2 Bacterial	Metabolic Disease Inflammation/Immunology
CD31 (PECAM-1) is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). CD31 is also an ER-MP12 antigen, acts as a linker between mechanical stress, metabolism and inflammation. CD31 peptide is able to sustain phosphorylation of the CD31 ITIM₆₈₆ and of SHP2 and to inhibit TCR-induced T-cell activation ^- .

HY-P10184

CD36 Peptide P (93-110), Cys conjugated	Peptides	Inflammation/Immunology
CD36 Peptide P (93-110), Cys conjugated is a Cys labelled CD36 Peptide, and can block binding of CD36 to immobilized thrombospondin and partially inhibited collagen-induced platelet aggregation .

HY-P3444A

CD31 TFA PECAM-1 TFA	SHP2 Bacterial	Metabolic Disease Inflammation/Immunology
CD31 (PECAM-1) TFA is platelet endothelial cell adhesion molecule-1, serves as the endothelial cell-specific receptor of clostridium perfringens b-Toxin (CPB). CD31 TFA is also an ER-MP12 antigen, acts as a linker between mechanical stress, metabolism and inflammation. CD31 TFA peptide is able to sustain phosphorylation of the CD31 ITIM₆₈₆ and of SHP2 and to inhibit TCR-induced T-cell activation ^- .

HY-P2983

Angiotensin-converting enzyme ACE; kininase II; CD143	Endogenous Metabolite	Cardiovascular Disease
Angiotensin-converting enzyme (ACE) is a dicarboxypeptidase, it converts inactive Angiotensin I (Ang I) to active Ang II and degrades active bradykinin (BK). Angiotensin-converting enzyme is a potent vasoconstrictor, is often used in biochemical studies .

HY-P4205

Aminopeptidase N Ligand (CD13) NGR peptide	Aminopeptidase	Cancer
Aminopeptidase N Ligand (CD13) NGR peptide is a polypeptide targeting *CD13* and can be used as a carrier to mediate intracellular transmission. Aminopeptidase N Ligand (CD13) NGR peptide is often used in cancer research .

HY-P3983

[Cys(Bzl)84] CD (81-92)

Peptides Others

[Cys(Bzl)84] CD (81-92) is an acidic peptide. [Cys(Bzl)84] CD (81-92) can be sequencing by negative ion postsource decay (PSD) spectra .

HY-P5322

Thrombospondin (TSP-1)-derived CD36 binding motif	Peptides	Others
Thrombospondin (TSP-1)-derived CD36 binding motif is a biological active peptide. (This peptide is derived from thrombospondin and represents a binding motif responsible for thrombospondin-CD36 interaction. It is cyclized through a disulfide bond. Thrombospondin is a matrix-bound glycoprotein involved in cancer metastasis, tumor adhesion, and angiogenesis. This peptide has been shown to competitively inhibit platelet aggregation and tumor metastasis.)

HY-P3325

P8RI D-P8RI	Peptides	Inflammation/Immunology
P8RI (D-P8RI) is a biomimetic peptide of CD31 and a *CD31* agonist. P8RI binds to the juxtamembrane amino acid sequence of the ectodomain of CD31, shows an immunosuppressive effect through restoration of the CD31 inhibitory pathway .

HY-P3554

Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl	HIV	Infection
Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl (compound (CPF(LL)) is an HIV-1 inhibitor. Carbomethoxycarbonyl-D-Pro-D-Phe-OBzl interacts with gp120 to block gp120 binding to *CD4* and preserve *CD4*-dependent T cell function .

HY-P0272

Peptide T

HIV Infection

Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a ligand for the CD4 receptor and prevents binding of HIV to the CD4 receptor.

HY-P3968

Thrombospondin-1 (1016-1021) (human, bovine, mouse)	Peptides	Others
Thrombospondin-1 (1016-1021) (human, bovine, mouse), a Thrombospondin-1-derived peptide, is a truncated peptide devoid of CD47-binding activity .

HY-P2230

Angstrom6 A6 Peptide	PAI-1	Cancer
Angstrom6 (A6 Peptide) is an 8 amino-acid peptide derived from single-chain urokinase plasminogen activator (scuPA) and interferes with the uPA/uPAR cascade and abrogates downstream effects. Angstrom6 binds to CD44 resulting in the inhibition of migration, invasion, and metastasis of tumor cells, and the modulation of CD44-mediated cell signaling .

HY-P2969

Complement factor I	Endogenous Metabolite	Metabolic Disease
Complement factor I is a serine protease that downregulates complement activity in the fluid phase and/or on cell surfaces in conjunction with one of its cofactors, factor H (FH), complement receptor 1 (CR1/CD35), C4 binding protein (C4BP) or membrane cofactor protein (MCP/CD46) .

HY-P5425

Tetanus Toxin (830–844)	Peptides	Others
Tetanus Toxin (830–844) is a biological active peptide. (tetanus toxin-derived peptide TT830–844 CD4+ T-cell epitope. This promiscuous CD4+ T-cell epitope can bind to a wide range of HLA–DRB molecules and is thus expected to activate CD4+ T-cell responses in a large part of the human population)

HY-P0272A

Peptide T TFA	HIV	Infection
Peptide T (TFA) is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a ligand for the *CD4* receptor and prevents binding of HIV to the CD4 receptor.

HY-P5966

Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse MOG (40-54)	Peptides	Inflammation/Immunology
Myelin Oligodendrocyte Glycoprotein (40-54), Rat, Mouse (MOG (40-54)) is a CD8-related self-antigenic epitope of the myelin oligodendrocyte glycoprotein (MOG) protein and is presented in association with H-2Db .

HY-P1698

Reltecimod AB-103	Bacterial CD28	Infection Inflammation/Immunology
Reltecimod (AB-103) is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod can be used to research necrotizing soft-tissue infections (NSTIs) .

HY-P2284

AD 01	Peptides	Cancer
AD 01, a 24 amino acid peptide of FKBPL (FK506-binding protein like), possesses potent anti-angiogenic activity. AD 01 bind to the CD44 receptor and inhibit tumour cell migration in a CD44 dependant manner .

HY-P5453

CFP10 (71–85)	Peptides	Others
CFP10 (71–85) is a biological active peptide. (CFP1071–85, that elicited IFN-γ production and CTL activity by both CD4+ and CD8+ T cells from persons expressing multiple MHC class II and class I molecules)

HY-P1698B

Reltecimod TFA AB-103 TFA	Bacterial CD28	Infection Inflammation/Immunology
Reltecimod (AB-103) TFA is a T-cell-specific surface glycoprotein CD28 (TP44) antagonist. Reltecimod TFA has beneficial effects against different bacterial infections, their exotoxins and endotoxins, and ionizing radiation. Reltecimod TFA modulates the inflammatory response by targeting and attenuating the critical CD28/B7-2 co-stimulatory pathway, without inhibiting it. Reltecimod TFA can be used to research necrotizing soft-tissue infections (NSTIs) .

HY-P3970

KRFK	TGF-β Receptor	Inflammation/Immunology
KRFK, a peptide derived from TSP-1, can activate TGF-β. KRFK promotes TGF-β-mediated signaling and its downstream role, independent of thrombospondin (TSP) receptors such as CD47 and CD36. KRFK can be used for chronic ocular surface inflammatory disorders reseach .

HY-P3970A

KRFK TFA 1 Publications Verification	TGF-β Receptor	Inflammation/Immunology
KRFK TFA, a peptide derived from TSP-1, can activate TGF-β. KRFK TFA promotes TGF-β-mediated signaling and its downstream role, independent of thrombospondin (TSP) receptors such as CD47 and CD36. KRFK TFA can be used for chronic ocular surface inflammatory disorders reseach .

HY-P4628

TPNQRQNVC

LRH-1 peptide
Peptides Inflammation/Immunology

TPNQRQNVC is a nonapeptide and is the epitope of HLA-B0702. TPNQRQNVC induces a CD8+ T cell immune response .

HY-P0168

Cibinetide 4 Publications Verification ARA290	Peptides	Neurological Disease
Cibinetide (ARA290) is an EPO-derivative, acting as a specific agonist of erythropoietin/CD131 heteroreceptor, and used for neurological disease treatment.

HY-P5442

MOG (44-54), mouse, human, rat

Peptides Others

MOG (44-54), mouse, human, rat is a biological active peptide. (minimal binding epitope for the CD8 + MOG‐specific T cell)
HY-P2511

Insulin β Chain Peptide (15-23)

Peptides Metabolic Disease

Insulin β Chain Peptide (15-23) is one of the earliest antigenic epitopes to which CD8 T-cells respond .

HY-P1302

Orphanin FQ(1-11)	Opioid Receptor	Neurological Disease
Orphanin FQ(1-11), a orphanin FQ or nociceptin (OFQ/N) fragment, is a potent NOP receptor (ORL-1; OP4) agonist, with a K_i of 55 nM. Orphanin FQ(1-11) has no affinity for μ, δ, κ1 and κ3 receptors (K_i>1000 nM). Orphanin FQ(1-11) is analgesic in CD-1 mice .

HY-P4032

HCV Peptide (35-44)	HCV	Inflammation/Immunology
HCV Peptide (35-44), a HCV core protein at positions 35 to 44, is a HLA-A2-restricted CTL epitope. HCV Peptide (35-44) inhibits NK cell activity via two distinct mechanisms, directly via KIR2DL2/3, and synergistically via the CD94:NKG2A receptor .

HY-P5413

[Lys3]-Bombesin	Peptides	Others
[Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)

HY-P1302A

Orphanin FQ(1-11) TFA	Opioid Receptor	Neurological Disease
Orphanin FQ(1-11) TFA, a orphanin FQ or nociceptin (OFQ/N) fragment, is a potent NOP receptor (ORL-1; OP4) agonist, with a K_i of 55 nM. Orphanin FQ(1-11) TFA has no affinity for μ, δ, κ1 and κ3 receptors (K_i>1000 nM). Orphanin FQ(1-11) TFA is analgesic in CD-1 mice .

HY-P4045

HBV Seq2 aa:208-216

HBV Infection

HBV Seq2 aa:208-216, a HBsAg derived CD8 epitope peptide, is studied as part of Large envelope protein from Hepatitis B virus .

HY-103048A

PD-1/PD-L1-IN 3 TFA	PD-1/PD-L1	Cancer
PD-1/PD-L1-IN 3 TFA, a macrocyclic peptide, is a potent and selective inhibitor of the PD-1/PD-L1 and *CD80/PD-L1* interactions extracted from patent WO2014151634A1, compound No.1. PD-1/PD-L1-IN 3 TFA interferes with PD-L1 binding to PD-1 and CD80 by binding to PD-L1, with IC₅₀s of 5.60 nM and 7.04 nM, respectively. PD-1/PD-L1-IN 3 TFA can be used for the research of various diseases, including cancer and infectious diseases .

HY-P1065

Apelin-36(rat, mouse)	Apelin Receptor (APJ) HIV	Infection Cardiovascular Disease Metabolic Disease
Apelin-36(rat, mouse) is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-36(rat, mouse) binds to APJ receptors with an IC₅₀ of 5.4 nM, and potently inhibits cAMP production with an EC₅₀ of 0.52 nM. Apelin-36(rat, mouse) blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ .

HY-P1066

Apelin-17(human, bovine)	Apelin Receptor (APJ) HIV	Infection
Apelin-17(human, bovine) is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-17(human, bovine) binds to human APJ receptors expressed in HEK 293 cells (pIC₅₀=9.02). Apelin-17(human, bovine) inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .

HY-P0144

Thrombospondin-1 (1016-1023) (human, bovine, mouse)	Apoptosis	Inflammation/Immunology
Thrombospondin-1 (1016-1023) (human, bovine, mouse), is the C-terminal end of the native sequence of Thrombospondin-1 (TSP-1), is a *CD47* agonist peptide .

HY-P1066A

Apelin-17(human, bovine) TFA	HIV Apelin Receptor (APJ)	Infection
Apelin-17(human, bovine) TFA is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-17(human, bovine) TFA binds to human APJ receptors expressed in HEK 293 cells (pIC₅₀=9.02). Apelin-17(human, bovine) TFA inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .

HY-P1065A

Apelin-36(rat, mouse) TFA	HIV Apelin Receptor (APJ)	Infection Cardiovascular Disease Metabolic Disease
Apelin-36(rat, mouse) TFA is an endogenous orphan G protein-coupled receptor APJ agonist. Apelin-36(rat, mouse) TFA binds to APJ receptors with an IC₅₀ of 5.4 nM, and potently inhibits cAMP production with an EC₅₀ of 0.52 nM. Apelin-36(rat, mouse) TFA blocks entry of some HIV-1 and HIV-2 strains into NP-2/CD4 cells expressing APJ .

HY-P5745

TYVPANASL

Peptides Cancer

TYVPANASL is a MHC I-binding CD8 T cell epitope of nine amino acids from HER2/neu. TYVPANASL can be used to prepare J-LEAPS vaccine .

HY-P1043A

NGR peptide Trifluoroacetate	Aminopeptidase	Cancer
NGR peptide Trifluoroacetatecontaining the Asn-Gly-Arg (NGR) motif. NGR peptide Trifluoroacetate binds to APN/CD13. NGR peptide Trifluoroacetate is directly conjugated to imaging agents that can be used for tumor imaging .

HY-P1043

NGR peptide	Aminopeptidase	Cancer
NGR peptide containing the Asn-Gly-Arg (NGR) motif. NGR peptide binds to APN/CD13. NGR peptide is directly conjugated to imaging agents that can be used for tumor imaging .

HY-P5930

HOXB7 8–25 MDM2 32-46	Ligands for E3 Ligase	Cancer
HOXB7 8–25 (MDM2 32-46) is an MDM2-derived peptide epitope and can elicit antigen-specifc and tumor-reactive CD4 ⁺ T cell responses .

HY-P5745A

TYVPANASL TFA

Peptides Cancer

TYVPANASL TFA is a MHC I-binding CD8 T cell epitope of nine amino acids from HER2/neu. TYVPANASL TFA can be used to prepare J-LEAPS vaccine .

HY-P10144

Ac-Orn-Phe-Arg-AMC	Fluorescent Dye	Others
Ac-Orn-Phe-Arg-AMC is a potent fluorescent substrate of *cd–Tryptase* and β 1-Tryptase. Ac-Orn-Phe-Arg-AMC releases amino-4-methylcoumarin (AMC) for fluorescence detection .

HY-P4145

Quazomotide	Peptides	Inflammation/Immunology Cancer
Quazomotide is a WT1 class II peptide epitope with sequences of RSDELVRHHNMHQRNMTKL. Quazomotide stimulates a peptide-specific CD4(+) response, to recognize WT1(+) tumor cells. Quazomotide is an immunological agent for active immunization, as well as an antineoplastic agent .

HY-P1064

Apelin-36(human)	Apelin Receptor (APJ) HIV	Infection Cardiovascular Disease Metabolic Disease
Apelin-36(human) is an endogenous orphan G protein-coupled receptor APJ agonist, with an EC₅₀ of 20 nM. Apelin-36(human) shows high affinity to human APJ receptors expressed in HEK 293 cells (pIC₅₀=8.61). Apelin-36 has been linked to two major types of biological activities: cardiovascular and metabolic. Apelin-36(human) inhibits the entry of some HIV-1 and HIV-2 into the NP2/CD4 cells expressing APJ .

HY-P1624

Teduglutide ALX-0600	Peptides	Inflammation/Immunology
Teduglutide is a dipeptidyl peptidase IV resistant glucagon-like peptide 2 (GLP-2) analogue. Teduglutide is associated with trophic effects on gut mucosa. Teduglutide can be used for the research of short bowel syndrome (SBS) and Crohn's disease (CD) .

HY-P4015

VIP (1-12), human, porcine, rat, ovine	Peptides	Neurological Disease Metabolic Disease
VIP (1-12), human, porcine, rat, ovine is a vasoactive intestinal peptide (VIP) fragment. VIP (1-12), human, porcine, rat, ovine is a ligand for the CD4 (T4)/human immunodeficiency virus receptor .

Cat. No.	Product Name

HY-K1064

Exosome Protein Detection Kit (CD63 & TSG101)
MCE Exosome Protein Detection Kit (CD63&TSG101) can specifically detect exosome proteins CD63 and TSG101. This product is suitable for the detection of human, rat and mouse exosomes.

HY-K0304

Human CD3+ T Cells Negative Selection Kit
MCE Human CD3⁺ T Cells Negative Selection Kit is designed for the isolation of CD3⁺ T cells from human peripheral blood mononuclear cells (PBMC).

HY-K0310

Mouse CD8⁺ Cell Positive Selection Kit
MCE Mouse CD8⁺ Cells Positive Selection Kit is designed for the isolation of CD8⁺ cells from single cell suspensions of mouse spleen cells, lymph nodes or other tissues.

HY-K0308

Mouse CD4+ Cell Positive Selection Kit
MCE Mouse CD4⁺ T Cells Positive Selection Kit is designed for the isolation of CD4⁺ cells from single cell suspensions of mouse spleen cells, lymph nodes or other tissues.

HY-K0306

Mouse CD3+ T Cells Negative Selection Kit
MCE Mouse CD3⁺ T Cells Negative Selection Kit is designed for the isolation of CD3⁺ T cells from single cell suspensions of mouse spleen cells, lymph nodes or other tissues.

HY-K0307

Mouse CD4+ T Cells Negative Selection Kit
MCE Mouse CD4⁺ T Cells Negative Selection Kit is designed for the isolation of CD4⁺ T cells from single cell suspensions of mouse spleen cells, lymph nodes or other tissues.

HY-K0309

Mouse CD8+ T Cells Negative Selection Kit
MCE Mouse CD8⁺ T Cells Negative Selection Kit is designed for the isolation of CD8⁺ T cells from single cell suspensions of mouse spleen cells, lymph nodes or other tissues.

HY-K0305

Human CD34+ Cells Negative Selection Kit
MCE Human CD34⁺ Cells Negative Selection Kit is designed for the isolation of CD34⁺ cells from human cord blood mononuclear cells (CBMC) or human peripheral blood mononuclear cells (PBMC).

Cat. No.	Product Name	Target	Research Area

HY-P99057

Varlilumab

CDX-1127
TNF Receptor Cancer

Varlilumab (CDX-1127) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .

HY-P99125

Anti-Mouse CD16/CD32 Antibody (2.4G2)	Inhibitory Antibodies	Inflammation/Immunology
Anti-Mouse CD16/CD32 Antibody (2.4G2) is an anti-mouse CD16/CD32 IgG2b antibody inhibitor derived from host Rat.

HY-P990017

Englumafusp alfa CD19-4-1BBL; RO7227166; RG6076	CD19	Cancer
Englumafusp alfa (CD19-4-1BBL; RO7227166) is a fusion construct comprised of a *CD19*-specific antibody domain fused to a trimerized extracellular domains of human 41BBL. Englumafusp alfa promotes CD19-specific 4-1BB cross-linking on the surface of T and NK cells .

HY-P99844

Davoceticept ALPN-202; CD80 vIgD-Fc	CTLA-4	Others
Davoceticept (ALPN-202; CD80 vIgD-Fc) is a monoclonal antibody targeting CTLA-4. Davoceticept consists of the (1-107) fragment of CD80 linked to IGHG1 Fc via a peptidyl linker. The expression system of Davoceticept is usually CHO (Chinese Hamster Ovary) cells .

HY-P99842

Dapirolizumab pegol CDP 7657	Inhibitory Antibodies	Cancer
Dapirolizumab pegol (CDP 7657) is a Fab'-IgG-κ class monoclonal antibody targeting CD40LG/TNFSF5 conjugated to a pegol moiety. Dapirolizumab pegol was originally cloned from the Norway rat (Rattus norvegicus).

HY-P990134

Anti-Mouse CD40L/CD154 Antibody (MR-1)	Inhibitory Antibodies	Others
Anti-Mouse CD40L/CD154 Antibody (MR-1) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CD40L/CD154.

HY-P990265

Anti-Mouse CD69 Antibody (CD69.2.2)

Inhibitory Antibodies Others

Anti-Mouse CD69 Antibody (CD69.2.2) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse CD69.

HY-P990136

Anti-Monkey/Human CD28 Antibody (CD28.2)	Inhibitory Antibodies	Others
Anti-Monkey/Human CD28 Antibody (CD28.2) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to monkey/human CD28.

HY-P990133

Anti-Monkey/Human CD40L/CD154 Antibody (5C8)	Inhibitory Antibodies	Others
Anti-Monkey/Human CD40L/CD154 Antibody (5C8) is a mouse-derived IgG2a type antibody inhibitor, targeting to monkey/human CD40L/CD154.

HY-P990290

Anti-Mouse CD16/CD32 (LALA-PG) Antibody (2.4G2-CP026)	Inhibitory Antibodies	Others
Anti-Mouse CD16/CD32 (LALA-PG) Antibody (2.4G2-CP026) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD16/CD32.

HY-P990269

Anti-Mouse CD40L/CD154 (LALA-PG) Antibody (MR-1-CP034)	Inhibitory Antibodies	Others
Anti-Mouse CD40L/CD154 (LALA-PG) Antibody (MR-1-CP034) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD40L/CD154.

HY-P990270

Anti-Mouse CD40L/CD154 (D265A) Antibody (MR-1-CP032)	Inhibitory Antibodies	Others
Anti-Mouse CD40L/CD154 (D265A) Antibody (MR-1-CP032) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse CD40L/CD154.

HY-P990268

Anti-Mouse CD45.2 Antibody (104.2)

Inhibitory Antibodies Others

Anti-Mouse CD45.2 Antibody (104.2) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD45.2.

HY-P990131

Anti-Mouse CD47/IAP Antibody (MIAP301)	Inhibitory Antibodies	Others
Anti-Mouse CD47/IAP Antibody (MIAP301) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD47/IAP.

HY-P99131

Anti-Mouse CD90.2 Antibody (30H12)

Inhibitory Antibodies Inflammation/Immunology

Anti-Mouse CD90.2 Antibody is an anti-mouse CD90.2 IgG2b antibody inhibitor derived from host Rat.
HY-P990291

Anti-Mouse CD16.2 Antibody (9E9)

Inhibitory Antibodies Others

Anti-Mouse CD16.2 Antibody (9E9) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CD16.2.

HY-P990277

Anti-Mouse CD31/PECAM-1 Antibody (390)	Inhibitory Antibodies	Others
Anti-Mouse CD31/PECAM-1 Antibody (390) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD31/PECAM-1.

HY-P990276

Anti-Mouse CD317/BST2 Antibody (927)	Inhibitory Antibodies	Others
Anti-Mouse CD317/BST2 Antibody (927) is a rat-derived IgG2b, κ type antibody inhibitor, targeting to mouse CD317/BST2.

HY-P9913A

Rituximab (anti-CD20) Maximum Cited Publications 6 Publications Verification	CD20	Inflammation/Immunology Cancer
Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer .

HY-P99302

Lulizumab Humanized Anti-CD28 Recombinant Antibody	CD28	Inflammation/Immunology
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is a selective *CD28* blockade, Lulizumab prevents T cell activation by selectively targeting CD28 signaling .

HY-P990002

Anti-Mouse CD117 Antibody

c-Kit Cancer

Anti-Mouse CD117 Antibody is an IgG2b antibody inhibitor against mouse CD117. Derived from rat.
HY-P990111

BMS-986325 (anti-CD40)

TNF Receptor Inflammation/Immunology

BMS-986325 (anti-CD40) is a CD40 inhibitor, and can be used for primary Sjögren's syndrome research .

HY-P990275

Anti-Mouse CD326/EpCAM Antibody (G8.8)	Inhibitory Antibodies	Others
Anti-Mouse CD326/EpCAM Antibody (G8.8) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD326/EpCAM.

HY-P99603

Cifurtilimab SEA-CD40	Inhibitory Antibodies	Cancer
Cifurtilimab (SEA-CD40) is an agonistic nonfucosylated, human IgG1 monoclonal antibody directed against *CD40*. Cifurtilimab shows antitumor activities .

HY-P99057A

Varlilumab (anti-CD27)

TNF Receptor Cancer

Varlilumab (anti-CD27) is a first-in-class human IgG1 anti-CD27 monoclonal antibody. Varlilumab has an anti-tumor activity .

HY-P990115

Anti-Mouse OX40/CD134 Antibody (OX-86)	Inhibitory Antibodies	Others
Anti-Mouse OX40/CD134 Antibody (OX-86) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse OX40/CD134.

HY-P990129

Anti-Mouse CD71/TfR1 Antibody (8D3)

Inhibitory Antibodies Others

Anti-Mouse CD71/TfR1 Antibody (8D3) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse CD71/TfR1.

HY-P990132

Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410)	Inhibitory Antibodies	Others
Anti-Mouse/Rat/Human CD47/IAP Antibody (MIAP410) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to mouse/rat/human CD47/IAP.

HY-P9976A

Isatuximab (anti-CD38) 1 Publications Verification	CD38	Cancer
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .

HY-P99303

Lumiliximab Anti-CD23 Recombinant Antibody	Inhibitory Antibodies	Inflammation/Immunology
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses .

HY-P990254

Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173)	Inhibitory Antibodies	Others
Anti-Mouse CXCR3/CD183 Antibody (CXCR3-173) is a Armenian hamster-derived IgG type antibody inhibitor, targeting to mouse CXCR3/CD183.

HY-P990154

Anti-Mouse TIM-1/CD365 Antibody (3B3)	Inhibitory Antibodies	Others
Anti-Mouse TIM-1/CD365 Antibody (3B3) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse TIM-1/CD365.

HY-P990127

Anti-Mouse CD80/B7-1 Antibody (RM80)

Inhibitory Antibodies Others

Anti-Mouse CD80/B7-1 Antibody (RM80) is a rat-derived IgG2a type antibody inhibitor, targeting to mouse CD80/B7-1.

HY-P990166

Anti-Mouse PSGL-1/CD162 Antibody (4RA10)	Inhibitory Antibodies	Others
Anti-Mouse PSGL-1/CD162 Antibody (4RA10) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse PSGL-1/CD162.

HY-P990249

Anti-Mouse DR5/CD262 Antibody (MD5-1)	Inhibitory Antibodies	Others
Anti-Mouse DR5/CD262 Antibody (MD5-1) is a Armenian hamster-derived IgG, κ type antibody inhibitor, targeting to mouse DR5/CD262.

HY-P990196

Anti-Monkey/Human MDR-1/CD243 Antibody (UIC2)	Inhibitory Antibodies	Others
Anti-Monkey/Human MDR-1/CD243 Antibody (UIC2) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to monkey/human MDR-1/CD243.

HY-P990284

Anti-Mouse CD205 Antibody (NLDC-145)

Inhibitory Antibodies Others

Anti-Mouse CD205 Antibody (NLDC-145) is a -derived type antibody inhibitor, targeting to mouse CD205.
HY-P990286

Anti-Rat CD2 Antibody (OX-34)

Inhibitory Antibodies Others

Anti-Rat CD2 Antibody (OX-34) is a -derived type antibody inhibitor, targeting to rat CD2.

HY-P990260

Anti-Mouse CD86/B7-2 Antibody (GL-1)	Inhibitory Antibodies	Others
Anti-Mouse CD86/B7-2 Antibody (GL-1) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD86/B7-2.

HY-P990130

Anti-Mouse/Rat CD71/TfR1 Antibody (OX-26)	Inhibitory Antibodies	Others
Anti-Mouse/Rat CD71/TfR1 Antibody (OX-26) is a mouse-derived IgG2a, κ type antibody inhibitor, targeting to mouse/rat CD71/TfR1.

HY-P99123

Anti-Mouse CD28 Antibody (37.51)

CD28 Inflammation/Immunology

Anti-Mouse CD28 Antibody is an anti-mouse CD28 IgG antibody inhibitor derived from the host Syrian Hamster.
HY-P99126

Anti-Mouse CD44 Antibody (IM7)

Inhibitory Antibodies Inflammation/Immunology

Anti-Mouse CD44 Antibody is an anti-mouse CD44 IgG2b antibody inhibitor derived from host Rat.
HY-P990128

Anti-Rat CD80/B7-1 Antibody (3H5)

Inhibitory Antibodies Others

Anti-Rat CD80/B7-1 Antibody (3H5) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to rat CD80/B7-1.

HY-P990294

Anti-Mouse CD106/VCAM-1 Antibody (M/K-2.7)	Inhibitory Antibodies	Others
Anti-Mouse CD106/VCAM-1 Antibody (M/K-2.7) is a rat-derived IgG1, κ type antibody inhibitor, targeting to mouse CD106/VCAM-1.

HY-P99976

Anti-Mouse CD19 Antibody (1D3)

CD19 Cancer

Anti-Mouse CD19 Antibody (1D3) is an anti-mouse CD19 IgG2a antibody inhibitor.
HY-P990137

Anti-Rat CD28 Antibody (JJ319)

Inhibitory Antibodies Others

Anti-Rat CD28 Antibody (JJ319) is a mouse-derived IgG1, κ type antibody inhibitor, targeting to rat CD28.
HY-P990259

Anti-Mouse CD96 Antibody (3.3)

Inhibitory Antibodies Others

Anti-Mouse CD96 Antibody (3.3) is a rat-derived IgG1, λ type antibody inhibitor, targeting to mouse CD96.
HY-P990139

Anti-Mouse CD20 Antibody (AISB12)

Inhibitory Antibodies Others

Anti-Mouse CD20 Antibody (AISB12) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD20.
HY-P990278

Anti-Mouse CD29 Antibody (KMI6)

Inhibitory Antibodies Others

Anti-Mouse CD29 Antibody (KMI6) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD29.
HY-P990295

Anti-Mouse CD103 Antibody (M290)

Inhibitory Antibodies Others

Anti-Mouse CD103 Antibody (M290) is a rat-derived IgG2a, κ type antibody inhibitor, targeting to mouse CD103.

Species:	Human (1214) Marmoset (2) Rhesus Macaque (134) Mouse (476) Rat (218) Bovine (1) E.coli (2) Cynomolgus (220) Rabbit (12) Dog (1) Canine (44) Pig (1)
Tag:	SUMO (18) His (1536) Tag Free (87) Avi (368) Myc (16) HSA (1) GST (20) MBP (1) Trx (5) Fc (732) Flag (43) B2M (1)
Source:	HEK293 (2129) E. coli Cell-free (18) CHO (6) CHO (9) Sf9 insect cells (3) P. pastoris (19) Sf9 insect cells (51) E. coli (81)

Cat. No.	Compare	Product Name	Species	Source

HY-P75320

	CTLA-4 Protein, Canine (HEK293, His) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Canine	HEK293
	CTLA-4 protein inhibits T-cell responses as a critical negative regulator, with a stronger affinity for CD80 and CD86 than CD28. This affinity allows CTLA-4 to effectively suppress T-cell activation and regulate immune responses, maintaining a delicate equilibrium in T-cell-mediated immunity. CTLA-4 Protein, Canine (HEK293, His) is the recombinant canine-derived CTLA-4 protein, expressed by HEK293 , with C-His labeled tag. The total length of CTLA-4 Protein, Canine (HEK293, His) is 161 a.a., with molecular weight of 19-25 kDa.

HY-P71466

	Cytosine deaminase/CodA Protein, E.coli (His-SUMO) codA; b0337; JW0328Cytosine deaminase; CD; CDA; CDase; EC 3.5.4.1; Cytosine aminohydrolase; Isoguanine deaminase; EC 3.5.4.-	E.coli	E. coli
	Cytosine deaminase (CodA) protein plays a key role in the pyrimidine salvage pathway by catalyzing the hydrolytic deamination of cytosine to uracil. This enzyme activity enables cells to efficiently utilize cytosine for pyrimidine nucleotide synthesis. Cytosine deaminase/CodA Protein, E.coli (His-SUMO) is the recombinant E. coli-derived Cytosine deaminase/CodA protein, expressed by E. coli , with N-His, N-SUMO labeled tag. The total length of Cytosine deaminase/CodA Protein, E.coli (His-SUMO) is 426 a.a., with molecular weight of ~63.5 kDa.

HY-P71694

	MetC Protein, E.coli (E. coli, His) metC; b3008; JW2975Cystathionine beta-lyase MetC; CBL; CL; CD; EC 4.4.1.28; Cysteine lyase MetC; Cysteine-S-conjugate beta-lyase MetC	E.coli	E. coli
	MetC protein is a multifunctional enzyme that catalyzes the cleavage of cystathionine to homocysteine, pyruvate, and ammonia, which is essential for methionine biosynthesis. It also acts as a cysteine desulfurase, converting cysteine into sulfide. MetC Protein, E.coli (E. coli, His) is the recombinant E. coli-derived MetC protein, expressed by E. coli , with N-His labeled tag. The total length of MetC Protein, E.coli (E. coli, His) is 392 a.a., with molecular weight of ~46.8 kDa.

HY-P75321

	CTLA-4 Protein, Canine (HEK293, Fc) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Canine	HEK293
	CTLA-4 protein inhibits T-cell responses as a critical negative regulator, with a stronger affinity for CD80 and CD86 than CD28. This affinity allows CTLA-4 to effectively suppress T-cell activation and regulate immune responses, maintaining a delicate equilibrium in T-cell-mediated immunity. CTLA-4 Protein, Canine (HEK293, Fc) is the recombinant canine-derived CTLA-4 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CTLA-4 Protein, Canine (HEK293, Fc) is 161 a.a., with molecular weight of ~40.1 kDa.

HY-P75317

	CTLA-4 Protein, Mouse (Biotinylated, HEK293, His) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Mouse	HEK293
	CTLA-4 is a key inhibitory receptor that serves as a major negative regulator of T cell responses in immune regulation. Its unique property is that its affinity to B7 ligands (CD80/CD86) is significantly higher than that of CD28. CTLA-4 Protein, Mouse (Biotinylated, HEK293, His) is the recombinant mouse-derived CTLA-4 protein, expressed by HEK293 , with C-His labeled tag. The total length of CTLA-4 Protein, Mouse (Biotinylated, HEK293, His) is 127 a.a., with molecular weight of ~15.3 kDa.

HY-P72959

	CTLA-4 Protein, Human (HEK293) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Human	HEK293
	The CTLA-4 protein is a key inhibitory receptor and a major negative regulator of T cell responses in coordination of immune regulation. Its unique property is its significantly increased affinity for B7 ligands (CD80/CD86) compared with CD28. CTLA-4 Protein, Human (HEK293) is the recombinant human-derived CTLA-4 protein, expressed by HEK293 , with tag free. The total length of CTLA-4 Protein, Human (HEK293) is 126 a.a., with molecular weight of ~13.5 kDa.

HY-P74215

	CTLA-4 Protein, Rat (HEK293, His) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Rat	HEK293
	CTLA-4 protein inhibits T-cell responses by binding strongly to CD80 and CD86 receptors, surpassing CD28. This affinity allows CTLA-4 to effectively regulate T-cell activation and immune responses. The balance between inhibitory and stimulatory signals controlled by CTLA-4 and its ligands modulates T-cell-mediated immune reactions. CTLA-4 Protein, Rat (HEK293, His) is the recombinant rat-derived CTLA-4 protein, expressed by HEK293 , with C-His labeled tag. The total length of CTLA-4 Protein, Rat (HEK293, His) is 161 a.a., with molecular weight of 21-30 kDa.

HY-P74216

	CTLA-4 Protein, Rat (HEK293, Fc) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Rat	HEK293
	CTLA-4 protein inhibits T-cell responses by binding strongly to CD80 and CD86 receptors, surpassing CD28. This affinity allows CTLA-4 to effectively regulate T-cell activation and immune responses. The balance between inhibitory and stimulatory signals controlled by CTLA-4 and its ligands modulates T-cell-mediated immune reactions. CTLA-4 Protein, Rat (HEK293, Fc) is the recombinant rat-derived CTLA-4 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CTLA-4 Protein, Rat (HEK293, Fc) is 161 a.a., with molecular weight of ~40.5 kDa.

HY-P72958

	CTLA-4 Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) Cytotoxic T-lymphocyte associated protein 4; CTLA4; CD152	Rhesus Macaque	HEK293
	CTLA-4 protein acts as a primary inhibitory receptor, playing a major role in regulating T-cell responses. Its strong affinity for CD80 and CD86 receptors allows CTLA-4 to effectively suppress T-cell activation and maintain immune balance. This interplay is crucial for fine-tuning T-cell-mediated immunity. CTLA-4 Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) is the recombinant Rhesus Macaque-derived CTLA-4 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CTLA-4 Protein, Cynomolgus/Rhesus Macaque (HEK293, Fc) is 161 a.a., with molecular weight of ~52 kDa.

HY-P72124

	CD63 Protein, Mouse (GST) CD63CD63 antigen; CD antigen CD63	Mouse	E. coli
	The CD63 protein is an important cell surface receptor that activates multiple signaling cascades. It plays a role in integrin signaling, leading to activation of AKT, FAK/PTK2, and MAP kinases. CD63 Protein, Mouse (GST) is the recombinant mouse-derived CD63 protein, expressed by E. coli , with N-GST labeled tag. The total length of CD63 Protein, Mouse (GST) is 101 a.a., with molecular weight of ~38.5 kDa.

HY-P77603

	CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc) CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon	Cynomolgus	HEK293
	The CD3E/CD3 epsilon 1-27 peptide is critical in the TCR-CD3 complex, transmitting signals during T cell activation. When APC activates the TCR, CD3E undergoes LCK/FYN-mediated phosphorylation together with ITAM, initiating downstream signaling. CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc) is a recombinant protein dimer complex containing cynomolgus-derived CD3D-CD3E Heterodimer protein, expressed by HEK293 , with C-hFc labeled tag. CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc), has molecular weight of 58-62 kDa.

HY-P77604

	CD3D-CD3E Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc) CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon	Cynomolgus	HEK293
	The CD3E/CD3 epsilon 1-27 peptide is critical in the TCR-CD3 complex, transmitting signals during T cell activation. When APC activates the TCR, CD3E undergoes LCK/FYN-mediated phosphorylation together with ITAM, initiating downstream signaling. CD3D-CD3E Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc) is a recombinant protein dimer complex containing cynomolgus-derived CD3D-CD3E Heterodimer protein, expressed by HEK293 , with C-hFc labeled tag. CD3D-CD3E Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc), has molecular weight of 58-62 kDa.

HY-P77605

	CD3E-CD3G Heterodimer Protein, Cynomolgus (HEK293, Fc) CD3; CD3G; CD3g; T3G; CD3e; CD3E; CD3 epsilon&CD3 gamma; CD3E&CD3G	Cynomolgus	HEK293
	CD3E/CD3 epsilon 1-27 peptide, crucial in the TCR-CD3 complex, transmits signals during T-cell activation. As APCs activate the TCR, CD3E, with ITAMs, undergoes LCK/FYN-mediated phosphorylation, initiating downstream signaling. Beyond signaling, CD3E contributes to T-cell development, forming CD3D/CD3E and CD3G/CD3E heterodimers. It regulates TCR-CD3 internalization through endocytosis sequences and interacts with CD6, NCK1, and NUMB, essential for internalization and degradation. The TCR-CD3 complex, including CD3D/CD3E and CD3G/CD3E heterodimers and CD3Z homodimers, demonstrates versatility in TCR assembly, allowing substitution of TCRalpha and TCRbeta with TCRgamma and TCRdelta. CD3E-CD3G Heterodimer Protein, Cynomolgus (HEK293, Fc) is a recombinant protein dimer complex containing cynomolgus-derived CD3E-CD3G Heterodimer protein, expressed by HEK293, with C-hFc labeled tag. CD3E-CD3G Heterodimer Protein, Cynomolgus (HEK293, Fc), has molecular weight of 36.9 kDa(CD3E) & 36.5 kDa(CD3G), respectively.

HY-P77606

	CD3E-CD3G Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc) CD3; CD3G; CD3g; T3G; CD3e; CD3E; CD3 epsilon&CD3 gamma; CD3E&CD3G	Cynomolgus	HEK293
	CD3E/CD3 epsilon 1-27 peptide, crucial in the TCR-CD3 complex, transmits signals during T-cell activation. As APCs activate the TCR, CD3E, with ITAMs, undergoes LCK/FYN-mediated phosphorylation, initiating downstream signaling. Beyond signaling, CD3E contributes to T-cell development, forming CD3D/CD3E and CD3G/CD3E heterodimers. It regulates TCR-CD3 internalization through endocytosis sequences and interacts with CD6, NCK1, and NUMB, essential for internalization and degradation. The TCR-CD3 complex, including CD3D/CD3E and CD3G/CD3E heterodimers and CD3Z homodimers, demonstrates versatility in TCR assembly, allowing substitution of TCRalpha and TCRbeta with TCRgamma and TCRdelta. CD3E-CD3G Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc) is a recombinant protein dimer complex containing cynomolgus-derived CD3E-CD3G Heterodimer protein, expressed by HEK293, with C-hFc labeled tag. CD3E-CD3G Heterodimer Protein, Cynomolgus (Biotinylated, HEK293, Fc), has molecular weight of 44-46 kDa.

HY-P77609

	CD3E-CD3G Heterodimer Protein, Human (HEK293, His) CD3; CD3G; CD3g; T3G; CD3e; CD3E; CD3 epsilon&CD3 gamma; CD3E&CD3G	Human	HEK293
	CD3 epsilon, a crucial part of the TCR-CD3 complex on T-lymphocytes, facilitates TCR-mediated signal transmission. When APCs activate TCR, CD3 epsilon, with CD3D, CD3G, and CD3Z, relays signals across the cell membrane via ITAMs. LCK and FYN phosphorylate CD3 epsilon upon TCR engagement, initiating downstream signaling. Essential for T-cell development, CD3 epsilon forms heterodimers, initiating TCR-CD3 complex assembly. It's vital for TCR-CD3 complex internalization and down-regulation, interacting with CD6, NCK1, and NUMB, underscoring its pivotal role in T-cell processes. CD3E-CD3G Heterodimer Protein, Human (HEK293, His) is a recombinant protein dimer complex containing human-derived CD3E-CD3G Heterodimer protein, expressed by HEK293, with C-His labeled tag. CD3E-CD3G Heterodimer Protein, Human (HEK293, His), has molecular weight of 25-40 kDa.

HY-P77610

	CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc) CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon	Human	HEK293
	CD3D Protein, an integral part of the TCR-CD3 complex on T-lymphocytes, plays a pivotal role in adaptive immunity. It transmits signals through CD3D, CD3E, CD3G, and CD3Z chains upon TCR engagement. CD3D is essential for thymocyte differentiation, ensuring proper TCR-CD3 complex assembly and surface expression. Interacting with CD4 and CD8 coreceptors, CD3D establishes a functional link crucial for CD4 or CD8 T-cell activation and positive selection. Its multifaceted role orchestrates intricate T-cell responses. CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc) is a recombinant protein dimer complex containing human-derived CD3D-CD3E Heterodimer protein, expressed by HEK293, with C-hFc labeled tag. CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc), has molecular weight of 40-53 kDa.

HY-P77611

	CD3E-CD3G Heterodimer Protein, Human (HEK293, Fc) CD3; CD3G; CD3g; T3G; CD3e; CD3E; CD3 epsilon&CD3 gamma; CD3E&CD3G	Human	HEK293
	CD3 epsilon, a crucial part of the TCR-CD3 complex on T-lymphocytes, facilitates TCR-mediated signal transmission. When APCs activate TCR, CD3 epsilon, with CD3D, CD3G, and CD3Z, relays signals across the cell membrane via ITAMs. LCK and FYN phosphorylate CD3 epsilon upon TCR engagement, initiating downstream signaling. Essential for T-cell development, CD3 epsilon forms heterodimers, initiating TCR-CD3 complex assembly. It's vital for TCR-CD3 complex internalization and down-regulation, interacting with CD6, NCK1, and NUMB, underscoring its pivotal role in T-cell processes. CD3E-CD3G Heterodimer Protein, Human (HEK293, Fc) is a recombinant protein dimer complex containing human-derived CD3E-CD3G Heterodimer protein, expressed by HEK293, with C-hFc labeled tag. CD3E-CD3G Heterodimer Protein, Human (HEK293, Fc), has molecular weight of 40-60 kDa.

HY-P77614

	CD3D-CD3E Heterodimer Protein, Mouse (HEK293, Fc) CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon	Mouse	HEK293
	The CD3D protein is a crucial component of the TCR-CD3 complex on T-lymphocytes, essential for adaptive immune responses. Upon TCR activation by APCs, CD3D, along with CD3E, CD3G, and CD3Z, transmits signals through ITAMs, activating downstream pathways. CD3D is vital for proper thymocyte differentiation, ensuring intracellular TCR-CD3 complex assembly. Dysfunctional complexes impair thymocyte differentiation. CD3D also interacts with CD4 and CD8, linking TCR to coreceptors for CD4 or CD8 T-cell activation and positive selection. The CD3D contributes to the intricate network governing T-cell responses. CD3D-CD3E Heterodimer Protein, Mouse (HEK293, Fc) is a recombinant protein dimer complex containing mouse-derived CD3D-CD3E Heterodimer protein, expressed by HEK293, with C-hFc labeled tag. CD3D-CD3E Heterodimer Protein, Mouse (HEK293, Fc), has molecular weight of 50-65 kDa.

HY-P700677

	CD3D-CD3E Heterodimer Protein, Human (Biotinylated, HEK293, His) CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon	Human	HEK293
	CD3 epsilon, a crucial part of the TCR-CD3 complex on T-lymphocytes, facilitates TCR-mediated signal transmission. When APCs activate TCR, CD3 epsilon, with CD3D, CD3G, and CD3Z, relays signals across the cell membrane via ITAMs. LCK and FYN phosphorylate CD3 epsilon upon TCR engagement, initiating downstream signaling. Essential for T-cell development, CD3 epsilon forms heterodimers, initiating TCR-CD3 complex assembly. It's vital for TCR-CD3 complex internalization and down-regulation, interacting with CD6, NCK1, and NUMB, underscoring its pivotal role in T-cell processes. CD3E-CD3D Heterodimer Protein, Human (Biotinylated, HEK293, His) is a recombinant protein dimer complex containing human-derived CD3E-CD3D Heterodimer protein, expressed by HEK293, with C-His labeled tag. CD3E-CD3D Heterodimer Protein, Human (Biotinylated, HEK293, His), has molecular weight of 25-40 kDa.

HY-P700678

	CD3E-CD3G Heterodimer Protein, Human (Biotinylated, HEK293, His) CD3; CD3G; CD3g; T3G; CD3e; CD3E; CD3 epsilon&CD3 gamma; CD3E&CD3G	Human	HEK293
	CD3 epsilon, a crucial part of the TCR-CD3 complex on T-lymphocytes, facilitates TCR-mediated signal transmission. When APCs activate TCR, CD3 epsilon, with CD3D, CD3G, and CD3Z, relays signals across the cell membrane via ITAMs. LCK and FYN phosphorylate CD3 epsilon upon TCR engagement, initiating downstream signaling. Essential for T-cell development, CD3 epsilon forms heterodimers, initiating TCR-CD3 complex assembly. It's vital for TCR-CD3 complex internalization and down-regulation, interacting with CD6, NCK1, and NUMB, underscoring its pivotal role in T-cell processes. CD3E-CD3G Heterodimer Protein, Human (Biotinylated, HEK293, His) is a recombinant protein dimer complex containing human-derived CD3E-CD3G Heterodimer protein, expressed by HEK293, with C-His labeled tag. CD3E-CD3G Heterodimer Protein, Human (Biotinylated, HEK293, His), has molecular weight of 25-40 kDa.

HY-P77612

	CD3D-CD3E Heterodimer Protein, Human (Biotinylated, HEK293, Fc-Avi) CD3; CD3e; CD3E; CD3d; T3D; CD3D; CD3E&CD3D; CD3 delta&CD3 epsilon	Human	HEK293
	CD3D Protein, an integral part of the TCR-CD3 complex on T-lymphocytes, plays a pivotal role in adaptive immunity. It transmits signals through CD3D, CD3E, CD3G, and CD3Z chains upon TCR engagement. CD3D is essential for thymocyte differentiation, ensuring proper TCR-CD3 complex assembly and surface expression. Interacting with CD4 and CD8 coreceptors, CD3D establishes a functional link crucial for CD4 or CD8 T-cell activation and positive selection. Its multifaceted role orchestrates intricate T-cell responses. CD3D-CD3E Heterodimer Protein, Human (Biotinylated, HEK293, Fc-Avi) is a recombinant protein dimer complex containing human-derived CD3D-CD3E Heterodimer protein, expressed by HEK293, with C-Avi, C-hFc labeled tag. CD3D-CD3E Heterodimer Protein, Human (Biotinylated, HEK293, Fc-Avi), has molecular weight of 48-60 kDa.

HY-P77613

	CD3E-CD3G Heterodimer Protein, Human (Biotinylated, HEK293, Fc-Avi) CD3; CD3G; CD3g; T3G; CD3e; CD3E; CD3 epsilon&CD3 gamma; CD3E&CD3G	Human	HEK293
	CD3 epsilon, a crucial part of the TCR-CD3 complex on T-lymphocytes, facilitates TCR-mediated signal transmission. When APCs activate TCR, CD3 epsilon, with CD3D, CD3G, and CD3Z, relays signals across the cell membrane via ITAMs. LCK and FYN phosphorylate CD3 epsilon upon TCR engagement, initiating downstream signaling. Essential for T-cell development, CD3 epsilon forms heterodimers, initiating TCR-CD3 complex assembly. It's vital for TCR-CD3 complex internalization and down-regulation, interacting with CD6, NCK1, and NUMB, underscoring its pivotal role in T-cell processes. CD3E-CD3G Heterodimer Protein, Human (Biotinylated, HEK293, Fc-Avi) is a recombinant protein dimer complex containing human-derived CD3E-CD3G Heterodimer protein, expressed by HEK293, with C-Avi, C-hFc labeled tag. CD3E-CD3G Heterodimer Protein, Human (Biotinylated, HEK293, Fc-Avi), has molecular weight of 48-55 kDa.

HY-P72740

	CD70 Protein, Human (HEK293, Fc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in human contains transmembrane domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Human (HEK293, Fc) is 149 amino acids in length (Q45-P193) and is expressed in the HEK293 cells with C terminal hFc-tag.

HY-P72741

	CD70 Protein, Mouse (HEK293, His) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Mouse	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in mouse contains TNF_2 domain (60-190 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Mouse (HEK293, Fc) is 149 amino acids in length (Q47-P195) and is expressed in the HEK293 cells with N terminal 10*His-tag.

HY-P72928

	CD70 Protein, Mouse (HEK293, Fc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Mouse	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in mouse contains TNF_2 domain (60-190 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Mouse (HEK293, Fc) is 149 amino acids in length (Q47-P195) and is expressed in the HEK293 cells with N terminal mFc-tag.

HY-P72929

	CD70 Protein, Rat (HEK293, Fc) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Rat	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in rat contains TNF_2 domain (57-188 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Rat (HEK293, Fc) is 150 amino acids in length (Q46-P195) and is expressed in the HEK293 cells with N terminal hFc-tag.

HY-P72930

	CD70 Protein, Rat (HEK293, His) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Rat	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in rat contains TNF_2 domain (57-188 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Rat (HEK293, His) is 150 amino acids in length (Q46-P195) and is expressed in the HEK293 cells with N terminal His-tag.

HY-P700035AF

	Animal-Free CD70 Protein, Human (His) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	E. coli
	As a ligand of CD27, CD70 protein is an indispensable part of T cell immune coordination and is of particular importance in antiviral responses. The CD70-CD27 pathway emerged as a key player that contributes to the generation and maintenance of T cell-mediated immune responses. Animal-Free CD70 Protein, Human (His) is the recombinant human-derived animal-FreeCD70 protein, expressed by E. coli , with N-His labeled tag. The total length of Animal-Free CD70 Protein, Human (His) is 155 a.a., with molecular weight of ~18.08 kDa.

HY-P75387

	CD70 Protein, Human (HEK293, Fc-Avi) CD70 antigen; CD70; CD27 ligand; CD27LG; TNFSF7; CD27L	Human	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in human contains transmembrane domain and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Human (HEK293, Fc-Avi) is 155 amino acids in length (Q39-P193) and is expressed in the HEK293 cells with N terminal hFc- and Avi-tag.

HY-P76802

	CD3D-CD3E Heterodimer Protein, Rhesus Macaque CD3E & CD3D; CD3 delta & CD3 epsilon; CD3 delta/epsilon	Rhesus Macaque	HEK293
	The CD3D protein is an important component of the TCR-CD3 complex on T lymphocytes and is critical for adaptive immune responses. After APC activates TCR, CD3D, together with CD3E, CD3G and CD3Z, transmits signals through ITAM and activates downstream pathways. CD3D-CD3E Heterodimer Protein, Rhesus Macaque is a recombinant protein dimer complex containing Rhesus Macaque-derived CD3D-CD3E Heterodimer protein, expressed by HEK293 , with tag free. CD3D-CD3E Heterodimer Protein, Rhesus Macaque, has molecular weight of ~52 & 43 kDa, respectively.

HY-P78405

	CD30 Ligand/TNFSF8 Protein, Human (HEK293, mFc) CD153; CD30 Ligand; CD30L; CD30-L; CD30LGMGC138144; TNFSF8; CD30LG	Human	HEK293
	CD30 Ligand is a B cell surface antigen and a ligand for CD30 (TNFRSF8), playing an inhibitory role in CD40-mediated immunoglobulin class switching. CD30 Ligand is also a a marker for Hodgkin lymphoma and related hematologic malignancies, involves in activation and functioning of the T cell-dependent immune system. CD30 ligand is expressed by T and B lymphocytes, macrophages, and a variety of normal haematopoietic cells and derived tumours. CD30 ligand exerts pleiotropic effects on normal and malignant lymphoid cells, including death, differentiation, or cell division. As for CD30 ligand in human is a type II membrane-associated glycoprotein belonging to the tumor necrosis factor (TNF) family. CD30 Ligand/TNFSF8 Protein, Human (HEK293, mFc) is 172 amino acids in length (Q63-D234) and is expressed in the HEK293 cells with a N-terminal mFc-tag.

HY-P72726

	CD3D-CD3E Heterodimer Protein, Human (HEK293, His) CD3E & CD3D; CD3 delta & CD3 epsilon; CD3 delta/epsilon	Human	HEK293
	CD3D Protein, an integral part of the TCR-CD3 complex on T-lymphocytes, plays a pivotal role in adaptive immunity. It transmits signals through CD3D, CD3E, CD3G, and CD3Z chains upon TCR engagement. CD3D is essential for thymocyte differentiation, ensuring proper TCR-CD3 complex assembly and surface expression. Interacting with CD4 and CD8 coreceptors, CD3D establishes a functional link crucial for CD4 or CD8 T-cell activation and positive selection. Its multifaceted role orchestrates intricate T-cell responses. CD3D-CD3E Heterodimer Protein, Human (HEK293, His) is a recombinant protein dimer complex containing human-derived CD3D-CD3E Heterodimer protein, expressed by HEK293, with C-6*His labeled tag. CD3D-CD3E Heterodimer Protein, Human (HEK293, His), has molecular weight of 16-30 kDa.

HY-P77616

	CD4 Protein, Rhesus Macaque (HEK293, His) CD4 antigen (p55); CD4 molecule; CD4 receptor; CD4; CD4mut; EU3	Rhesus Macaque	HEK293
	CD4 Protein forms surface dimers, interacts with LCK and PTK2/FAK1, and binds to P4HB/PDI. It induces CD4-dependent signaling with IL16. CD4 interacts with MHCII alpha and beta chains, increasing TCR affinity. Oligomerization of CD4 is necessary for stable MHCII binding and T cell-APC adhesion. CD4 Protein, Rhesus Macaque (HEK293, His) is the recombinant Rhesus Macaque-derived CD4 protein, expressed by HEK293 , with C-His labeled tag. The total length of CD4 Protein, Rhesus Macaque (HEK293, His) is 365 a.a., with molecular weight of 45-52 kDa.

HY-P78410

	CD4 Protein, Human (HEK293, His-Avi) CD4 antigen (p55); CD4 molecule; CD4 receptor; CD4; CD4mut; EU3	Human	HEK293
	The CD4 protein is an integral membrane glycoprotein that plays a key role in immune responses. In T cells, it serves as a coreceptor for MHC class II molecules, interacting with T cell receptors and initiating intracellular signaling pathways. CD4 Protein, Human (HEK293, His-Avi) is the recombinant human-derived CD4 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of CD4 Protein, Human (HEK293, His-Avi) is 365 a.a., with molecular weight of 50-60 kDa.

HY-P74318

	CD24 Protein, Rat (HEK293, Fc) Signal transducer CD24; CD24; CD24A	Rat	HEK293
	The CD24 protein plays a critical role in cellular differentiation in various cell types, possibly triggered by binding of lectin-like ligands to the CD24 carbohydrate. This signal is transduced through second messengers released from GPI anchors. CD24 Protein, Rat (HEK293, Fc) is the recombinant rat-derived CD24 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CD24 Protein, Rat (HEK293, Fc) is 29 a.a., with molecular weight of 45-57 kDa.

HY-P76237

	CD3E-CD3G Heterodimer Protein, Rhesus Macaque (HEK293, Fc) CD3E & CD3G; CD3 epsilon & CD3 gamma; CD3 epsilon/gamma	Rhesus Macaque	HEK293
	CD3E protein has predicted functions such as SH3 domain binding and protein heterodimerization, and plays a crucial role in nervous system development and cell adhesion. It is involved in T cell activation, cytokine production and signal transduction. CD3E-CD3G Heterodimer Protein, Rhesus Macaque (HEK293, Fc) is a recombinant protein dimer complex containing Rhesus Macaque-derived CD3E-CD3G Heterodimer protein, expressed by HEK293 , with C-hFc labeled tag. CD3E-CD3G Heterodimer Protein, Rhesus Macaque (HEK293, Fc), has molecular weight of ~83 (40 + 43) KDa.

HY-P78090

	CD4 Protein, Human (Biotinylated, HEK293, His-Avi) CD4 antigen (p55); CD4 molecule; CD4 receptor; CD4; CD4mut; EU3	Human	HEK293
	The CD4 protein is an integral membrane glycoprotein that plays a key role in immune responses. In T cells, it serves as a coreceptor for MHC class II molecules, interacting with T cell receptors and initiating intracellular signaling pathways. CD4 Protein, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived CD4 protein, expressed by HEK293 , with C-Avi, C-His labeled tag. The total length of CD4 Protein, Human (Biotinylated, HEK293, His-Avi) is 365 a.a., with molecular weight of 50-60 kDa.

HY-P72122

	CD40L/CD154/TRAP Protein, Rabbit (His) CD40LG; CD40L; TNFSF5CD40 ligand; CD40-L; Tumor necrosis factor ligand superfamily member 5; CD antigen CD154; CD40 ligand; membrane form; CD40 ligand; soluble form; sCD40L;	Rabbit	E. coli
	CD40L (CD154; TRAP) is a ligand to CD40/TNFRSF5, acts function by generating a costimulatory signal that up-regulates IL-4 synthesis. CD40L is specifically expressed on activated CD4+ T-lymphocytes and involves in activation of NF-κB/MAPK pathway. CD40L also involves in B cell differentiation, maturation, and apoptosis. CD40L in Rabbit, cleaved into a soluble form, acts as a ligand for integrins (ITGA5:ITGB1 and ITGAV:ITGB3). CD40L/CD154/TRAP Protein, Rabbit (His) has a total length of 149 amino acids (M113-L261), is expressed in E. coli cells with N-terminal 6*His-tag.

HY-P7144

	CD40L/CD154/TRAP Protein, Human rHuCD40L; CD154; TRAP; TNFSF5; CD40LG; CD40-L	Human	E. coli
	CD40L (CD154; TRAP) is a ligand to CD40/TNFRSF5, acts function by generating a costimulatory signal that up-regulates IL-4 synthesis. CD40L is specifically expressed on activated CD4+ T-lymphocytes and involves in activation of NF-κB/MAPK pathway. CD40L also involves in B cell differentiation, maturation, and apoptosis. CD40L in human, cleaved into 2 chains of membrane form (1-261 a.a.) and soluble form (113-261 a.a.) which serves as a ligand for integrins (ITGA5:ITGB1 and ITGAV:ITGB3). CD40L/CD154/TRAP Protein, Human has a total length of 149 amino acids (M113-L261), is expressed in E. coli cells with tag free.

HY-P70609G

	GMP CD40L/CD154/TRAP Protein, Human (HEK293) CD40 ligand; CD40-L; TRAP; CD154; TNFSF5	Human	HEK293
	CD40L (CD154; TRAP) is a ligand to CD40/TNFRSF5, acts function by generating a costimulatory signal that up-regulates IL-4 synthesis. CD40L is specifically expressed on activated CD4+ T-lymphocytes and involves in activation of NF-κB/MAPK pathway. CD40L also involves in B cell differentiation, maturation, and apoptosis. CD40L in human, cleaved into 2 chains of membrane form (1-261 a.a.) and soluble form (113-261 a.a.) which serves as a ligand for integrins (ITGA5:ITGB1 and ITGAV:ITGB3). CD40L/CD154/TRAP Protein, Human (HEK293) has a total length of 149 amino acids (M113-L261), is expressed in HEK293 cells with tag free.

HY-P76775

	CD160 Protein, Rhesus Macaque (HEK293) CD160 antigen; CD160	Rhesus Macaque	HEK293
	CD160 Protein, a member of the immunoglobulin 'superfamily' of proteins that binds weakly to MHC I and stimulates NK and CD8⁺ T‐cell activation. CD160 Protein, Rhesus Macaque (HEK293) is the recombinant Rhesus Macaque-derived CD160 protein, expressed by HEK293 , with tag free. The total length of CD160 Protein, Rhesus Macaque (HEK293) is 158 a.a., with molecular weight of ~15.6 KDa.

HY-P72121

	CD40L/CD154/TRAP Protein, Rhesus macaque (His) CD40LG; CD40L; TNFSF5CD40 ligand; CD40-L; Tumor necrosis factor ligand superfamily member 5; CD antigen CD154; CD40 ligand; membrane form; CD40 ligand; soluble form; sCD40L;	Rhesus Macaque	E. coli
	CD40L (CD154; TRAP) is a ligand to CD40/TNFRSF5, acts function by generating a costimulatory signal that up-regulates IL-4 synthesis. CD40L is specifically expressed on activated CD4+ T-lymphocytes and involves in activation of NF-κB/MAPK pathway. CD40L also involves in B cell differentiation, maturation, and apoptosis. CD40L in Rhesus macaque, cleaved into 2 chains of membrane form (1-261 a.a.) and soluble form (113-261 a.a.) which serves as a ligand for integrins (ITGA5:ITGB1 and ITGAV:ITGB3). CD40L/CD154/TRAP Protein, Rhesus macaque (His) has a total length of 218 amino acids (V44-L261), is expressed in E. coli cells with N-terminal 6*His-tag.

HY-P72907

	CD40L/CD154/TRAP Protein, Human (His) CD40 ligand; CD40-L; TRAP; CD154; sCD40L; TNFSF5	Human	E. coli
	CD40L (CD154; TRAP) is a ligand to CD40/TNFRSF5, acts function by generating a costimulatory signal that up-regulates IL-4 synthesis. CD40L is specifically expressed on activated CD4+ T-lymphocytes and involves in activation of NF-κB/MAPK pathway. CD40L also involves in B cell differentiation, maturation, and apoptosis. CD40L in human, cleaved into 2 chains of membrane form (1-261 a.a.) and soluble form (113-261 a.a.) which serves as a ligand for integrins (ITGA5:ITGB1 and ITGAV:ITGB3). CD40L/CD154/TRAP Protein, Human (His) has a total length of 144 amino acids (E108-L261), is expressed in E. coli cells with C-terminal His-tag.

HY-P77596

	CD24 Protein-VLP, Cynomolgus (HEK293) CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043	Cynomolgus	HEK293
	CD24 Protein-VLP, Cynomolgus (HEK293) is recommended for animal immunization.

HY-P77597

	CD24 Protein, Cynomolgus (HEK293, Fc) CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043	Cynomolgus	HEK293
	CD24 protein plays a pivotal role in cell differentiation across various cell types, with signaling potentially initiated by lectin-like ligand binding to CD24 carbohydrates, transduced through second messengers released from the GPI-anchor. CD24 also modulates B-cell activation responses, promoting AG-dependent B-cell proliferation and preventing terminal differentiation into antibody-forming cells. In association with SIGLEC10, CD24 contributes to the selective suppression of the immune response to DAMPs such as HMGB1, HSP70, and HSP90, suggesting a role in immune regulation. Additionally, CD24 is implicated in controlling autoimmunity, exhibiting cell-type-specific interactions with LYN and FGR in diverse cellular processes and immune regulation. CD24 Protein, Cynomolgus (HEK293, Fc) is the recombinant cynomolgus-derived CD24 protein, expressed by HEK293 , with C-hFc labeled tag. The total length of CD24 Protein, Cynomolgus (HEK293, Fc) is 28 a.a., with molecular weight of 45-60 kDa.

HY-P78404

	CD24 Protein, Human (HEK293, mFc) CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043	Human	HEK293
	The CD24 protein plays a critical role in cellular differentiation in various cell types, and its signaling may be initiated by lectin-like ligands that bind to the CD24 carbohydrate and transduced by second messengers released from GPI anchors. CD24 also regulates B cell activation responses, promoting AG-dependent B cell proliferation and preventing terminal differentiation into antibody-forming cells. CD24 Protein, Human (HEK293, mFc) is the recombinant human-derived CD24 protein, expressed by HEK293 , with C-mFc labeled tag. The total length of CD24 Protein, Human (HEK293, mFc) is 33 a.a., with molecular weight of 48-60 kDa.

HY-P78544

CD24 Protein-VLP, Human (HEK293)

CD 24; CD24 molecule; CD24A; FLJ22950; FLJ43543; MGC75043
Human HEK293

CD24 Protein-VLP, Human (HEK293) is recommended for animal immunization.

HY-P70434

	CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc-Flag&Fc-His) CD3E & CD3D; CD3 delta & CD3 epsilon; CD3 delta /epsilon	Human	HEK293
	CD3D protein is a component of the TCR-CD3 complex on T lymphocytes and plays a key role in adaptive immunity. It transmits signals through the CD3D, CD3E, CD3G, and CD3Z chains upon TCR engagement. CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc-Flag&Fc-His) is a recombinant protein dimer complex containing human-derived CD3D-CD3E Heterodimer protein, expressed by HEK293 , with C-hFc, C-Flag, C-6*His labeled tag. CD3D-CD3E Heterodimer Protein, Human (HEK293, Fc-Flag&Fc-His), has molecular weight of 40-52 kDa.

HY-P72727

	CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc-Flag&Fc-His) CD3E & CD3D; CD3 delta & CD3 epsilon; CD3 delta/epsilon	Cynomolgus	HEK293
	CD3 δ protein is a component of the TCR-CD3 complex on T lymphocytes and plays a crucial role in adaptive immunity. Activated by APC, TCR signals through the CD3 chain, including CD3D, CD3E, CD3G, and CD3Z. CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc-Flag&Fc-His) is a recombinant protein dimer complex containing cynomolgus-derived CD3D-CD3E Heterodimer protein, expressed by HEK293 , with C-hFc, C-Flag, C-6*His labeled tag. CD3D-CD3E Heterodimer Protein, Cynomolgus (HEK293, Fc-Flag&Fc-His), has molecular weight of 40-60 kDa.

HY-P77620

	CD70 Protein, Cynomolgus (HEK293, His) CD70 molecule; CD70; TNFSF7; CD27 Ligand; CD27-L; CD27LG; Ki-24 antigen; TNFSF7G	Cynomolgus	HEK293
	CD70 is the ligand of CD27 in activated T and B lymphocytes, is an important cytokine in CD70-CD27 pathway involving with the generation and maintenance of T cell immunity. CD70 is a surface antigen, also shows antiviral activity and regulates viability of tumor cells and regulatory T cells. As for CD70 protein in cynomolgus contains TNF_2 domain (57-189 a.a) and transmembrane helix, belonging to the tumor necrosis factor (TNF) family. CD70 Protein, Cynomolgus (HEK293, His) is 156 amino acids in length (Q39-P194) and is expressed in the HEK293 cells with a N terminal His-tag.

Cat. No.	Product Name	Application	Reactivity

HY-P82843

DcR2 Antibody (YA2588) TNFRSF10D; DCR2; TRAILR4; TRUNDD; Tumor necrosis factor receptor superfamily member 10D; Decoy receptor 2; DcR2; TNF-related apoptosis-inducing ligand receptor 4; TRAIL receptor 4; TRAIL-R4; TRAIL receptor with a truncated death domain; CD	WB, IHC-P, ICC/IF	Human

HY-P82688

HLA DQA1 Antibody (YA2433)

HLA-DQA1; CD; CELIAC1; DQ-A1; GSE; HLA-DQA; DQ alpha 1 chain; DC-1 alpha chain; DC-alpha; HLA-DCA; MHC class II DQA1
WB, IHC-P, IP Human, Mouse, Rat

HY-P80604

CD63 Antibody CD63 antigen; CD63	WB, IHC-P	Human, Mouse
CD63 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD63. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P80591

CD105 Antibody ENG; END; Endoglin; CD antigen CD105	WB, IHC-P, IP	Human
CD105 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 71 kDa, targeting to CD105. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

HY-P80605

CD68 Antibody (YA799) CD68; Macrosialin; Gp110; CD68	IHC-P, ICC/IF	Human, Mouse
CD68 Antibody (YA799) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD68 (9H5). It can be used for IHC-P,ICC/IF assays with tag free, in the background of Human, Mouse.

HY-P81347

CD28 Antibody (YA1092)

CD28; T-cell-specific surface glycoprotein CD28; TP44; CD28
IHC-P Human
HY-P81664

CD70 Antibody (YA1409)

CD70; CD27LG; TNFSF7; TNFSF7G; CD27L
FC, ELISA Human

HY-P80595

CD146 Antibody CD146; MUC18	WB, IHC-F, IHC-P, ICC/IF	Human, Rat
CD146 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 72 kDa, targeting to CD146. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human, Rat.

HY-P82667

CD226 Antibody (YA2412)

CD226; DNAM1; CD226 antigen; DNAX accessory molecule 1; DNAM-1; CD antigen CD226
WB Human

HY-P80601

CD3G Antibody CD3 gamma; CD3g; T3G	WB, IHC-P, IP	Human
CD3G Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 20 kDa, targeting to CD3G. It can be used for WB,IHC-P,IP assays with tag free, in the background of Human.

HY-P81648

CD37 Antibody (YA1393)

CD37; TSPAN26; Leukocyte antigen CD37; Tetraspanin-26; Tspan-26; CD37
FC, ELISA Human
HY-P83241

CD1C Antibody (YA2986)

CD1C; T-cell surface glycoprotein CD1c; CD1c
WB Human

HY-P81098

CD34 Antibody CD34 antigen; CD34 molecule; Cluster designation 34; Hematopoietic progenitor cell antigen CD34; HPCA1; CD34_HUMAN.	WB; ELISA; IHC-P; IHC-F; Flow-Cyt; IF	Human, Mouse(predicted: Rat, Dog, Pig, Cow, Rabbit)
CD34 Antibody is an unconjugated, approximately 39 kDa, rabbit-derived, anti-CD34 polyclonal antibody. CD34 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, and predicted: rat, dog, pig, cow, rabbit background without labeling.

HY-P81659

CD5 Antibody (YA1404)

CD5; LEU1; T-cell surface glycoprotein CD5; Lymphocyte antigen T1/Leu-1; CD antigen CD5
IHC-P, IHC-F, Flow-Cyt, IF Human (predicted: Mouse, Rat)
HY-P82515

CD83 Antibody (YA2260)

CD83; CD83 antigen; hCD83; B-cell activation protein; Cell surface protein HB15; CD antigen CD83
WB Human, Mouse, Rat
HY-P81370

CD53 Antibody (YA1115)

CD53; MOX44; TSPAN25; Leukocyte surface antigen CD53; Cell surface glycoprotein CD53; Tetraspanin-25; Tspan-25; CD53
IHC-P Human
HY-P82695

CD55 Antibody (YA2440)

CD55; CR; DAF; Complement decay-accelerating factor; CD55
WB Human
HY-P81513

CD163L1 Antibody (YA1258)

CD163b; CD163L1; CD164L1; M160; Scart1
IHC-P Human

HY-P81184

CD80 Antibody (YA3386) Activation B7-1 antigen; B lymphocyte activation antigen B7; B7; B7-1; B7-1 antigen; BB1; CD28 antigen ligand 1; CD28LG; CD28LG1; CD80; CD80 antigen (CD28 antigen ligand 1, B7-1 antigen); CD80 antigen; CD80 molecule; CD80_HUMAN; Costimulatory factor CD80; costimulatory molecule variant IgV-CD80; CTLA-4 counter-receptor B7.1; LAB7; T-lymphocyte activation antigen CD80; CD80_RAT.	WB, IHC-P, Flow-Cyt, ICC	Human, Mouse (predicted: Rat)
CD80 Antibody is an unconjugated, approximately 30 kDa, mouse-derived, anti-CD80 monoclonal antibody. CD80 Antibody can be used for: WB, IHC-P,FC ICC expriments in mouse,human, and predicted: rat background without labeling.

HY-P80607

CD8 alpha Antibody CD8A; MAL; T-cell surface glycoprotein CD8 alpha chain; T-lymphocyte differentiation antigen T8/Leu-2; CD antigen CD8a	WB, IHC-P	Human, Hamster
CD8 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 26 kDa, targeting to CD8 alpha. It can be used for WB,IHC-P assays with tag free, in the background of Human, Hamster.

HY-P80597

CD19 Antibody (YA807) CD19; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD19	ICC/IF, FC	Human
CD19 Antibody (YA807) is a non-conjugated and Mouse origined monoclonal antibody, targeting to CD19 (3G7). It can be used for ICC/IF,FC assays with tag free, in the background of Human.

HY-P80600

CD3D Antibody CD3D; T3D; T-cell surface glycoprotein CD3 delta chain; T-cell receptor T3 delta chain; CD antigen CD3d	WB, IHC-F, IHC-P, ICC/IF, IP	Human
CD3D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 19 kDa, targeting to CD3D. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human.

HY-P80609

CD86 Antibody CD86; CD28LG2; T-lymphocyte activation antigen CD86; Activation B7-2 antigen; B70; BU63; CTLA-4 counter-receptor B7.2; FUN-1; CD antigen CD86	WB, IHC-P, ICC/IF, IP, FC	Human, Rat
CD86 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 38 kDa, targeting to CD86. It can be used for WB,IHC-P,ICC/IF,IP,FC assays with tag free, in the background of Human, Rat.

HY-P82680

Phospho-CD3 zeta (Tyr142) Antibody (YA2425)

CD247; CD3Z; T3Z; TCRZ; T-cell surface glycoprotein CD3 zeta chain; T-cell receptor T3 zeta chain; CD antigen CD247
WB, IP Human
HY-P81691

DNAM1 Antibody (YA1436)

CD226; DNAM1; CD226 antigen; DNAX accessory molecule 1; DNAM-1; CD antigen CD226
FC, ELISA Human
HY-P82215

CD89 Antibody (YA1960)

FCAR; CD89; Immunoglobulin alpha Fc receptor; IgA Fc receptor; CD89
WB, IHC-P, ICC/IF, IP, FC Human
HY-P82326

CD66b Antibody (YA2071)

CD66b; CD67; CEACAM8; CGM6; NCA95
WB Human
HY-P81373

CD69 Antibody (YA1118)

CLEC2C; CD69
IHC-P Human

HY-P80054

CD133 Antibody	WB, IHC-P, FC	Human, Mouse
CD133 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 97 kDa, targeting to CD133. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

HY-P80055

CD4 Antibody	WB, ICC/IF, IHC-P	Human
CD4 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to CD4. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

HY-P80056

CD40 Antibody	WB, ICC, IHC-P	Human
CD40 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to CD40. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

HY-P80058

CD41 Antibody	WB, IHC-P	Human
CD41 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 113 kDa, targeting to CD41. It can be used for WB,IHC-P assays with tag free, in the background of Human.

HY-P80061

CD43 Antibody	WB, IHC-P, FC	Human
CD43 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 40 kDa, targeting to CD43. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

HY-P80062

CD44 Antibody	WB, IHC-P, FC	Human, Mouse
CD44 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 82 kDa, targeting to CD44. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human, Mouse.

HY-P80064

CD46 Antibody	WB, ICC, IHC-P	Human, Rat
CD46 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 44 kDa, targeting to CD46. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Rat.

HY-P80065

CD47 Antibody	IHC-P	Human
CD47 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 35 kDa, targeting to CD47. It can be used for IHC-P assays with tag free, in the background of Human.

HY-P80069

CD90 Antibody	WB, IHC-P	Human, Rat
CD90 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 18 kDa, targeting to CD90. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.

HY-P80070

CD99 Antibody	WB, ICC/IF, IHC-P, IP, FC	Human
CD99 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 25 kDa, targeting to CD99. It can be used for WB,ICC/IF,IHC-P,IP,FC assays with tag free, in the background of Human.

HY-P80386

CD38 Antibody	WB, IHC-P, ICC	Human
CD38 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 34 kDa, targeting to CD38. It can be used for WB,IHC-P,ICC assays with tag free, in the background of Human.

HY-P80447

CD31 Antibody	WB, IHC-P, FC, IP	Human
CD31 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to CD31. It can be used for WB,IHC-P,FC,IP assays with tag free, in the background of Human.

HY-P80966

CD161 Antibody	WB, IHC-P, FC	Human
CD161 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 25 kDa, targeting to CD161. It can be used for WB, IHC-P, FC assays with tag free, in the background of Human.

HY-P80603

CD45 Antibody (YA800) PTPRC; CD45; Receptor-type tyrosine-protein phosphatase C; Leukocyte common antigen; L-CA; T200; CD antigen CD45	WB, IHC-P	Human, Mouse
CD45 Antibody (YA800) is a non-conjugated and Mouse origined monoclonal antibody about 147 kDa, targeting to CD45. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse.

HY-P83634

CD1a Antibody (YA3379)

CD1A; T-cell surface glycoprotein CD1a; T-cell surface antigen T6/Leu-6; hTa1 thymocyte antigen; CD antigen CD1a
WB, IHC-P Human
HY-P81668

B7-1 Antibody (YA1413)

CD80; CD28LG; CD28LG1; LAB7; T-lymphocyte activation antigen CD80; Activation B7-1 antigen; BB1; CTLA-4 counter-receptor B7.1; B7; CD antigen CD80
FC, ELISA Human
HY-P81630

CD200 Antibody (YA1375)

CD200; MOX1; MOX2; My033; OX-2 membrane glycoprotein; CD200
FC, ELISA Human
HY-P81870

CD32B Antibody (YA1615)

Fc fragment of IgG; low affinity IIb; receptor (CD32); CD32; FCG2; CD32B; FCGR2; IGFR2
WB, IHC-P Human, Rat

HY-P81508

CD13 Antibody (YA1253) ANPEP; APN; CD13; PEPN; Aminopeptidase N; AP-N; hAPN; Alanyl aminopeptidase; Aminopeptidase M; AP-M; Microsomal aminopeptidase; Myeloid plasma membrane glycoprotein CD13; gp150; CD antigen CD13	IHC-P	Human

HY-P80446

CD19 Antibody (YA543) CD19_HUMAN; B-lymphocyte antigen CD19; B-lymphocyte surface antigen B4; Differentiation antigen CD19; T-cell surface antigen Leu-12; CD_antigen: CD19; B-lymphocyte surface antigen B4; Leu 12; Leu12	WB, ICC/IF, IHC-P; FC	Human
CD19 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 61 kDa, targeting to CD19. It can be used for WB,ICC/IF,IHC-P assays with tag free, in the background of Human.

HY-P81660

CD7 Antibody (YA1405)

CD7; T-cell antigen CD7; GP40; T-cell leukemia antigen; T-cell surface antigen Leu-9; TP41; CD7
FC, ELISA Human

HY-P80599

CD31 Antibody (YA806) Platelet endothelial cell adhesion molecule; PECAM-1; EndoCAM; GPIIA'; PECA1; CD antigen CD31	WB, IF-Cell, IF-Tissue, IHC-P, FC, mIHC	Human
CD31 Antibody (YA806) is a non-conjugated and Mouse origined monoclonal antibody about 83 kDa, targeting to CD31 (2D3). It can be used for WB,IP assays with tag free, in the background of Human.

Cat. No.	Product Name		Classification

HY-152074

CD73-IN-14		Alkynes
D73-IN-14 is a potent, selective and orally active *CD73* inhibitor with an IC₅₀ value of 0.17 nM. CD73-IN-14 increases the number of tumor-infiltrating CD8 ⁺ cells and shows anti-tumor activity . CD73-IN-14 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-17413S1

Zidovudine-13C,d3 Azidothymidine-¹³C,d₃; AZT-¹³C,d₃; ZDV-¹³C,d₃		Azide
Zidovudine- ¹³C,d₃ is the ¹³C- and deuterium labeled Zidovudine. Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency. Zidovudine-13C,d3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. Strain-promoted alkyne-azide cycloaddition (SPAAC) can also occur with molecules containing DBCO or BCN groups.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

CD

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

MCE Kits

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Natural
Products